No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1962 |
4. Check minimum number of eventsNone |
1962 |
5. Include endpointsNone |
1962 |
6. Filter based on genotype QC (FinnGen only) |
1894 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Varicella [chickenpox]
based on the number of shared cases.
Similar with more cases:
- Varicella [chickenpox], including avohilmo
- Viral infections characterized by skin and mucous membrane lesions
- Viral infections characterized by skin and mucous membrane lesions, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 24317 | 7662 | 16552 |
| Only index persons | 20463 | 6106 | 14357 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.22 | 0.46 |
| Only index persons | 0.45 | 0.22 | 0.55 |
| Median age at first event (years) | |||
| Whole population | 15.07 | 5.26 | 19.52 |
| Only index persons | 15.83 | 6.61 | 19.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1894 | 622 | 1272 |
| Unadjusted period prevalence (%) | 0.46 | 0.22 | 0.58 |
| Median age at first event (years) | 17.54 | 12.06 | 20.21 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1962
- Matched controls
- 19620
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
05209
ICD-8 Finland
Chickenpox, Unspecified
+∞
307.7
638
*
B01.9
ICD-10 Finland
Varicella without complication
480.0
307.7
527
15
0529X
ICD-9 Finland
Chickenpox, Varicella without mention of complication
+∞
273.5
256
*
05200
ICD-8 Finland
Chickenpox, Cum meningoencephalitide
+∞
135.0
128
*
B01.8
ICD-10 Finland
Varicella with other complications
897.6
88.4
86
*
05201
ICD-8 Finland
Chickenpox, Cum complicatione alia
+∞
58.6
56
*
05207
ICD-8 Finland
Chickenpox, Suspectae
+∞
56.5
54
*
J05AB01
ATC
aciclovir; systemic
2.4
51.2
429
2042
L04AA01
ATC
[U] ciclosporin
10.3
49.7
56
56
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
45.0
43
*
J05AB11
ATC
valaciclovir; oral
2.5
41.7
291
1265
0528X
ICD-9 Finland
Chickenpox, With unspecified complication
+∞
37.6
36
*
H02AB09
ATC
hydrocortisone; systemic
4.5
33.9
85
197
B01AF, ,
ICD-10 Finland
+∞
33.4
32
*
L04AD01
ATC
ciclosporin; systemic
5.1
33.3
70
140
127
Kela drug reimbursment
Transplant complication
5.0
33.0
71
145
G02.0*B01.0
ICD-10 Finland
Varicella meningitis
+∞
31.3
30
*
0527A
ICD-9 Finland
Chickenpox, With other specified complications
+∞
29.2
28
*
L04AX01
ATC
azathioprine; systemic
3.2
27.8
112
361
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
8.6
25.8
33
39
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.4
23.5
88
271
R50.9
ICD-10 Finland
Fever, unspecified
1.9
21.9
322
1847
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
21.9
83
258
L04AA06
ATC
mycophenolic acid; systemic
3.8
20.7
63
169
B03XA01
ATC
erythropoietin; parenteral
7.5
20.4
29
39
602
Kela drug reimbursment
Children's severe malnutrition
6.4
19.3
32
51
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.9
18.8
56
148
A11CC03
ATC
alfacalcidol; systemic
3.7
18.3
58
160
05699
ICD-8 Finland
Rubella, Non definita
+∞
17.7
17
*
Z94.0
ICD-10 Finland
Kidney transplant status
4.4
17.6
44
102
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
17.2
102
406
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.0
16.8
47
119
C90.0
ICD-10 Finland
Multiple myeloma
7.4
16.5
24
33
B02.9
ICD-10 Finland
Zoster without complication
2.8
16.0
82
304
ZX120
NOMESCO Finland
Intravenous
2.1
15.9
158
787
H26.2
ICD-10 Finland
Complicated cataract
5.4
15.9
31
58
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
15.8
60
187
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
15.7
130
602
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
26.5
15.6
21
8
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
15.5
161
816
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.6
15.3
50
141
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
15.0
386
2571
J17.1*B01.2
ICD-10 Finland
Varicella pneumonia
+∞
14.6
14
*
B07.9
ICD-10 Finland
Verruca simplex
2.9
14.5
66
229
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13.5
14.2
24
18
L03AA02
ATC
filgrastim; parenteral
3.2
14.0
55
175
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
13.9
754
5879
L01BA01
ATC
methotrexate; systemic
3.1
13.9
59
197
H02AB04
ATC
methylprednisolone; systemic
1.8
13.8
210
1210
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
13.7
89
371
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
13.0
359
2427
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
12.9
246
1512
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.9
12.9
28
58
H02AB06
ATC
prednisolone; systemic
1.4
12.8
771
6110
XF602
NOMESCO Finland
Bloodpressure monitoring
4.7
12.6
29
63
BE00A, ,
NOMESCO Finland
70.3
12.6
14
*
WX882
NOMESCO Finland
High dependency care
2.6
12.6
70
271
B01AB, ,
ICD-10 Finland
+∞
12.5
12
*
05697
ICD-8 Finland
Rubella, Suspecta
+∞
12.5
12
*
0520B
ICD-9 Finland
Chickenpox, Postvaricella encephalitis[VARICELLA CUM PNEUMONITIDE]
+∞
12.5
12
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.3
12.5
25
48
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
12.4
95
427
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
12.4
159
868
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
12.3
363
2489
ZXD05
NOMESCO Finland
Urgent procedure
1.5
12.0
496
3647
R11
ICD-10 Finland
Nausea and vomiting
1.9
12.0
155
847
Z3231
NOMESCO Finland
Registered nurse
1.5
11.8
467
3406
A04AA01
ATC
ondansetron; systemic, rectal
2.0
11.8
121
611
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.3
11.7
44
137
B01.0
ICD-10 Finland
Varicella meningitis
+∞
11.5
11
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
11.3
138
740
A12AA04
ATC
calcium carbonate; oral
3.6
11.3
37
105
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
11.1
85
382
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.6
11.0
36
102
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
8.6
11.0
23
27
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.5
10.9
36
103
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
10.9
352
2457
B05DB
ATC
Hypertonic solutions
4.8
10.7
24
51
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
10.7
268
1764
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.7
10.7
33
90
B05DA
ATC
Isotonic solutions
4.4
10.5
26
60
05299, ,
ICD-8 Finland
+∞
10.4
10
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.5
10.4
20
37
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
10.4
60
237
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
16.1
10.3
16
10
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
12.1
10.3
18
15
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
10.3
56
215
137
Kela drug reimbursment
Uraemia requiring dialysis
4.1
10.2
27
66
A07AA02
ATC
nystatin; oral
2.4
10.0
70
303
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
1.7
10.0
201
1252
Z85.6
ICD-10 Finland
Personal history of leukaemia
16.8
9.9
15
9
TK800
NOMESCO Finland
Hemodialysis
2.8
9.7
48
175
L04AD02
ATC
tacrolimus; systemic
3.2
9.6
37
117
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
9.6
153
894
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
9.6
292
2009
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
9.6
122
665
Z2446
NOMESCO Finland
Social worker
1.8
9.4
141
808
C03CA01
ATC
furosemide; systemic
1.5
9.4
281
1924
0520A
ICD-9 Finland
Chickenpox, Postvaricella encephalitis[ENCEPHALITIS POST VARICELLAM]
+∞
9.4
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.1
9.4
37
119
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
9.3
92
458
JN6AD
NOMESCO Finland
CT of torso and neck
3.2
9.3
36
114
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.8
9.3
28
75
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.0
9.3
26
66
S01AD03
ATC
aciclovir; ophthalmic
2.9
9.1
41
142
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
9.0
90
450
J01DA01
ATC
[U] cefalexin
1.3
8.8
1008
8680
TAB00
NOMESCO Finland
Lumbar puncture
2.0
8.7
88
443
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
8.6
282
1966
B03XA02
ATC
darbepoetin alfa; parenteral
3.0
8.6
36
120
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
4.8
8.6
19
40
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.8
8.6
42
153
ZXE00
NOMESCO Finland
One hour or less
1.4
8.6
604
4835
R06AE07
ATC
cetirizine; oral
1.3
8.6
723
5948
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.0
8.6
86
432
A05AA02
ATC
ursodeoxycholic acid; oral
2.9
8.5
38
132
N18.8
ICD-10 Finland
Other chronic renal failure
3.1
8.4
35
116
J02AC01
ATC
fluconazole; systemic
1.4
8.4
494
3840
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
8.4
644
5221
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.9
8.3
95
499
B01.1
ICD-10 Finland
Varicella encephalitis
+∞
8.3
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.5
8.3
280
1965
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
8.2
158
972
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
6.5
8.2
20
31
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
8.1
306
2196
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
8.0
192
1248
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
8.0
166
1042
J01MA12
ATC
levofloxacin; systemic
1.5
8.0
250
1728
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
7.3
8.0
18
25
N05BA09
ATC
clobazam; oral
3.7
7.9
24
65
WW500
NOMESCO Finland
Blood transfusion
2.2
7.9
61
277
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
45.2
7.7
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.4
7.7
53
229
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
7.6
229
1567
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
8.1
7.6
16
20
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
7.6
287
2060
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.5
516
4100
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.6
7.5
40
153
J01DA06
ATC
[U] cefuroxime
1.5
7.4
211
1427
M04AA01
ATC
allopurinol; systemic
1.6
7.4
164
1048
L08.0
ICD-10 Finland
Pyoderma
4.0
7.3
20
50
J01DB01
ATC
cefalexin; oral
1.4
7.3
1523
14091
7101
FHL
Needle biopsy in the operating room
+∞
7.3
7
*
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
+∞
7.3
7
*
05599
ICD-8 Finland
Measles, Non definita
+∞
7.3
7
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.0
7.3
74
374
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
7.3
385
2934
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.4
7.3
25
74
ZXD00
NOMESCO Finland
Emergency procedure
2.3
7.2
52
229
A87.9
ICD-10 Finland
Viral meningitis, unspecified
4.3
7.2
18
42
W19
ICD-10 Finland
Unspecified fall
1.6
7.2
163
1048
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.5
7.1
24
70
ZXA10
NOMESCO Finland
Bilateral
1.5
7.1
230
1599
K06.18
ICD-10 Finland
Another gingival hyperplasia
6.6
7.1
17
26
Z49.2
ICD-10 Finland
Other dialysis
3.8
7.1
21
56
N05BB01
ATC
hydroxyzine; systemic
1.9
7.1
92
506
ZX121
NOMESCO Finland
Central venous catheter
5.6
7.1
19
34
S18
ICPC
Laceration/cut
1.3
7.0
746
6290
L04AA13
ATC
[U] leflunomide
2.7
7.0
35
129
ZX108
NOMESCO Finland
Inhalation
4.2
7.0
18
43
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.2
7.0
27
86
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
7.0
120
717
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
7.0
177
1168
3AC01, ,
NOMESCO Finland
3.7
6.9
21
57
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.3
6.8
25
77
B01AB05
ATC
enoxaparin; parenteral
1.4
6.8
398
3077
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
6.8
117
699
153
Kela drug reimbursment
Lenalidomid
8.3
6.8
14
17
Z94.4
ICD-10 Finland
Liver transplant status
6.1
6.8
17
28
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.8
98
558
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.1
6.7
63
309
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.7
402
3120
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
3.4
6.7
23
68
TGC00
NOMESCO Finland
Bronchial lavation
2.5
6.7
41
168
R4110
NOMESCO Finland
Physiotherapy
1.4
6.7
419
3275
JN4AD
NOMESCO Finland
Body CT examination
1.6
6.6
148
948
J01FF01
ATC
clindamycin; systemic
1.4
6.6
422
3308
H26.3
ICD-10 Finland
Drug-induced cataract
5.5
6.6
18
33
N99
ICPC
Neurological disease other
3.6
6.6
21
59
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
6.6
104
608
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
6.9
6.5
15
22
L04AX03
ATC
methotrexate; systemic
1.6
6.5
146
936
A10AB01
ATC
insulin (human); parenteral
2.0
6.5
65
328
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
5.7
6.4
17
30
5639
FHL
Other measure in this category
70.1
6.4
7
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
6.4
242
1734
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
6.4
345
2631
A10AA01, ,
ATC
2.2
6.4
52
242
AA1AD
NOMESCO Finland
CT of head and brain
1.4
6.3
369
2850
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
6.3
133
839
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
6.3
403
3156
A02BC02
ATC
pantoprazole; systemic
1.3
6.3
1071
9535
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
6.3
69
359
A10AA02, ,
ATC
2.1
6.3
54
257
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
6.3
63
318
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
6.3
6
*
B01AA, ,
ICD-10 Finland
+∞
6.3
6
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.2
441
3507
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
26.8
6.2
8
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.4
6.2
40
168
E0000UV, ,
ATC
1.3
6.2
659
5538
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.2
443
3531
L04AX04
ATC
lenalidomide; oral
7.7
6.1
13
17
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
6.1
62
314
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
6.1
58
287
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
10.0
6.0
11
11
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hematology
82 [38004501]
82 [38004501]
1.7e+00
2.6e+00
3.2e+00
1.0e+50
3.0e+00
2.6e+00
2.0e+00
cases:3.36%
controls:0.64%
cases:4.33%
controls:0.35%
cases:3.07%
controls:0.13%
cases:1.40%
controls:0.00%
cases:2.53%
controls:0.13%
cases:4.51%
controls:0.37%
cases:4.91%
controls:0.69%
24
44
691
6865
31
24
685
6891
22
9
694
6906
10
0
706
6915
18
9
694
6899
31
25
656
6784
31
43
601
6168
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
3.6e+00
3.8e+00
—
—
—
3.6e+00
3.3e+00
cases:3.64%
controls:0.10%
cases:3.91%
controls:0.09%
—
—
—
—
—
—
cases:3.78%
controls:0.10%
cases:4.43%
controls:0.18%
26
7
689
6902
28
6
688
6909
—
—
—
26
7
661
6802
28
11
604
6200
Internal Medicine
11 [38004456]
11 [38004456]
4.1e-01
8.1e-01
2.2e+00
6.0e+00
2.0e+00
1.1e+00
7.3e-01
cases:19.86%
controls:14.16%
cases:12.85%
controls:6.17%
cases:8.52%
controls:0.98%
cases:25.70%
controls:0.09%
cases:8.43%
controls:1.23%
cases:15.43%
controls:5.73%
cases:26.58%
controls:14.83%
142
978
573
5931
92
427
624
6488
61
68
655
6847
184
6
532
6909
60
85
652
6823
106
390
581
6419
168
921
464
5290
Nephrology
39 [38004479]
39 [38004479]
1.8e+00
2.2e+00
2.7e+00
—
2.7e+00
2.0e+00
1.4e+00
cases:2.38%
controls:0.41%
cases:2.93%
controls:0.32%
cases:1.54%
controls:0.10%
—
—
cases:1.54%
controls:0.10%
cases:2.18%
controls:0.29%
cases:2.85%
controls:0.72%
17
28
698
6881
21
22
695
6893
11
7
705
6908
—
11
7
701
6901
15
20
672
6789
18
45
614
6166
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
2.8e+00
3.1e+00
—
1.0e+50
—
3.3e+00
3.1e+00
cases:1.96%
controls:0.12%
cases:1.82%
controls:0.09%
—
—
cases:0.98%
controls:0.00%
—
—
cases:2.33%
controls:0.09%
cases:3.01%
controls:0.14%
14
8
701
6901
13
6
703
6909
—
7
0
709
6915
—
16
6
671
6803
19
9
613
6202
aciclovir; oral, parenteral
J05AB01 [21603131]
J05AB01 [21603131]
7.0e-01
1.6e+00
4.4e+00
—
4.8e+00
1.3e+00
6.2e-01
cases:3.08%
controls:1.55%
cases:2.93%
controls:0.64%
cases:5.45%
controls:0.07%
—
—
cases:12.22%
controls:0.12%
cases:2.33%
controls:0.62%
cases:3.48%
controls:1.90%
22
107
693
6802
21
44
695
6871
39
5
677
6910
—
87
8
625
6900
16
42
671
6767
22
118
610
6093
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.4e+00
1.5e+00
2.8e+00
1.0e+50
3.1e+00
1.5e+00
1.3e+00
cases:4.62%
controls:1.14%
cases:3.49%
controls:0.78%
cases:1.40%
controls:0.09%
cases:1.96%
controls:0.00%
cases:1.54%
controls:0.07%
cases:2.91%
controls:0.68%
cases:7.12%
controls:2.00%
33
79
682
6830
25
54
691
6861
10
6
706
6909
14
0
702
6915
11
5
701
6903
20
46
667
6763
45
124
587
6087
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.4e+00
1.5e+00
2.8e+00
1.0e+50
3.0e+00
1.5e+00
1.4e+00
cases:4.62%
controls:1.13%
cases:3.49%
controls:0.78%
cases:1.40%
controls:0.09%
cases:1.82%
controls:0.00%
cases:1.40%
controls:0.07%
cases:2.91%
controls:0.69%
cases:7.28%
controls:1.95%
33
78
682
6831
25
54
691
6861
10
6
706
6909
13
0
703
6915
10
5
702
6903
20
47
667
6762
46
121
586
6090
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.4e+00
1.7e+00
2.3e+00
—
3.1e+00
1.8e+00
1.3e+00
cases:4.62%
controls:1.22%
cases:3.77%
controls:0.74%
cases:1.26%
controls:0.13%
—
—
cases:2.11%
controls:0.10%
cases:3.35%
controls:0.59%
cases:5.54%
controls:1.58%
33
84
682
6825
27
51
689
6864
9
9
707
6906
—
15
7
697
6901
23
40
664
6769
35
98
597
6113
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.7e+00
3.2e+00
—
—
—
2.8e+00
2.8e+00
cases:1.96%
controls:0.13%
cases:1.68%
controls:0.07%
—
—
—
—
—
—
cases:1.60%
controls:0.10%
cases:2.53%
controls:0.16%
14
9
701
6900
12
5
704
6910
—
—
—
11
7
676
6802
16
10
616
6201
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.5e+00
1.5e+00
2.6e+00
1.0e+50
2.9e+00
1.5e+00
1.3e+00
cases:4.62%
controls:1.11%
cases:3.35%
controls:0.78%
cases:1.40%
controls:0.10%
cases:1.82%
controls:0.00%
cases:1.54%
controls:0.09%
cases:2.91%
controls:0.66%
cases:7.12%
controls:1.96%
33
77
682
6832
24
54
692
6861
10
7
706
6908
13
0
703
6915
11
6
701
6902
20
45
667
6764
45
122
587
6089
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
2.4e+00
3.2e+00
1.0e+50
—
—
3.4e+00
2.4e+00
cases:1.82%
controls:0.17%
cases:2.37%
controls:0.10%
cases:0.84%
controls:0.00%
—
—
—
—
cases:2.47%
controls:0.09%
cases:3.48%
controls:0.32%
13
12
702
6897
17
7
699
6908
6
0
710
6915
—
—
17
6
670
6803
22
20
610
6191
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.4e+00
2.4e+00
3.1e+00
—
1.8e+00
2.3e+00
1.7e+00
cases:3.64%
controls:0.96%
cases:4.47%
controls:0.42%
cases:1.96%
controls:0.09%
—
—
cases:0.70%
controls:0.12%
cases:4.37%
controls:0.44%
cases:6.01%
controls:1.13%
26
66
689
6843
32
29
684
6886
14
6
702
6909
—
5
8
707
6900
30
30
657
6779
38
70
594
6141
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
7.7e-01
1.4e+00
2.3e+00
—
3.4e+00
1.8e+00
1.1e+00
cases:3.64%
controls:1.72%
cases:3.21%
controls:0.81%
cases:1.40%
controls:0.14%
—
—
cases:2.53%
controls:0.09%
cases:3.78%
controls:0.66%
cases:6.33%
controls:2.13%
26
119
689
6790
23
56
693
6859
10
10
706
6905
—
18
6
694
6902
26
45
661
6764
40
132
592
6079
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
5.0e-01
9.0e-01
1.7e+00
3.9e+00
2.1e+00
8.5e-01
8.1e-01
cases:12.87%
controls:8.21%
cases:11.87%
controls:5.21%
cases:5.45%
controls:1.08%
cases:3.49%
controls:0.07%
cases:9.69%
controls:1.30%
cases:10.77%
controls:4.92%
cases:18.83%
controls:9.32%
92
567
623
6342
85
360
631
6555
39
75
677
6840
25
5
691
6910
69
90
643
6818
74
335
613
6474
119
579
513
5632
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
2.2e+00
2.9e+00
—
—
—
3.1e+00
2.4e+00
cases:1.26%
controls:0.14%
cases:1.54%
controls:0.09%
—
—
—
—
—
—
cases:1.89%
controls:0.09%
cases:3.01%
controls:0.29%
9
10
706
6899
11
6
705
6909
—
—
—
13
6
674
6803
19
18
613
6193
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
2.4e+00
2.9e+00
—
—
—
2.6e+00
2.5e+00
cases:1.54%
controls:0.14%
cases:2.23%
controls:0.13%
—
—
—
—
—
—
cases:2.04%
controls:0.16%
cases:2.69%
controls:0.23%
11
10
704
6899
16
9
700
6906
—
—
—
14
11
673
6798
17
14
615
6197
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
7.4e-01
1.6e+00
2.1e+00
—
2.7e+00
1.7e+00
1.3e+00
cases:3.78%
controls:1.84%
cases:4.75%
controls:0.95%
cases:1.82%
controls:0.22%
—
—
cases:2.81%
controls:0.20%
cases:4.37%
controls:0.85%
cases:8.07%
controls:2.27%
27
127
688
6782
34
66
682
6849
13
15
703
6900
—
20
14
692
6894
30
58
657
6751
51
141
581
6070
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
9.5e-01
1.9e+00
2.9e+00
1.0e+50
2.0e+00
2.2e+00
1.1e+00
cases:2.10%
controls:0.83%
cases:2.09%
controls:0.30%
cases:1.26%
controls:0.07%
cases:0.70%
controls:0.00%
cases:0.98%
controls:0.13%
cases:2.04%
controls:0.23%
cases:2.06%
controls:0.68%
15
57
700
6852
15
21
701
6894
9
5
707
6910
5
0
711
6915
7
9
705
6899
14
16
673
6793
13
42
619
6169
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.8e+00
3.4e+00
—
—
—
3.2e+00
1.6e+00
cases:2.66%
controls:0.43%
cases:4.33%
controls:0.14%
—
—
—
—
—
—
cases:3.35%
controls:0.15%
cases:3.01%
controls:0.61%
19
30
696
6879
31
10
685
6905
—
—
—
23
10
664
6799
19
38
613
6173
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
8.7e-01
2.1e+00
1.9e+00
—
2.4e+00
1.5e+00
1.2e+00
cases:3.22%
controls:1.38%
cases:4.75%
controls:0.59%
cases:0.98%
controls:0.14%
—
—
cases:1.26%
controls:0.12%
cases:2.77%
controls:0.63%
cases:5.70%
controls:1.75%
23
95
692
6814
34
41
682
6874
7
10
709
6905
—
9
8
703
6900
19
43
668
6766
36
109
596
6102
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.1e-01
4.6e-01
1.7e+00
4.7e+00
2.1e+00
4.7e-01
3.4e-01
cases:21.54%
controls:18.24%
cases:17.46%
controls:11.77%
cases:11.59%
controls:2.34%
cases:16.20%
controls:0.17%
cases:16.57%
controls:2.37%
cases:17.03%
controls:11.34%
cases:28.32%
controls:21.99%
154
1260
561
5649
125
814
591
6101
83
162
633
6753
116
12
600
6903
118
164
594
6744
117
772
570
6037
179
1366
453
4845
ursodeoxycholic acid; oral
A05AA02 [21600513]
A05AA02 [21600513]
1.9e+00
2.7e+00
—
—
—
2.8e+00
2.3e+00
cases:0.98%
controls:0.14%
cases:1.68%
controls:0.12%
—
—
—
—
—
—
cases:1.46%
controls:0.09%
cases:1.74%
controls:0.18%
7
10
708
6899
12
8
704
6907
—
—
—
10
6
677
6803
11
11
621
6200
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
5.9e-01
1.2e+00
2.2e+00
—
2.6e+00
1.6e+00
1.0e+00
cases:6.01%
controls:3.43%
cases:4.61%
controls:1.42%
cases:1.26%
controls:0.14%
—
—
cases:1.12%
controls:0.09%
cases:4.37%
controls:0.95%
cases:6.49%
controls:2.46%
43
237
672
6672
33
98
683
6817
9
10
707
6905
—
8
6
704
6902
30
65
657
6744
41
153
591
6058
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
6.5e-01
1.1e+00
2.5e+00
—
2.7e+00
1.2e+00
8.8e-01
cases:5.59%
controls:3.00%
cases:5.17%
controls:1.71%
cases:2.79%
controls:0.25%
—
—
cases:3.23%
controls:0.22%
cases:4.22%
controls:1.29%
cases:7.75%
controls:3.36%
40
207
675
6702
37
118
679
6797
20
17
696
6898
—
23
15
689
6893
29
88
658
6721
49
209
583
6002
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
7.3e-01
1.3e+00
2.0e+00
1.0e+50
2.1e+00
1.8e+00
1.2e+00
cases:6.29%
controls:3.13%
cases:4.05%
controls:1.10%
cases:1.12%
controls:0.16%
cases:0.70%
controls:0.00%
cases:1.12%
controls:0.14%
cases:4.22%
controls:0.75%
cases:7.75%
controls:2.42%
45
216
670
6693
29
76
687
6839
8
11
708
6904
5
0
711
6915
8
10
704
6898
29
51
658
6758
49
150
583
6061
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
2.2e+00
3.0e+00
—
—
—
2.1e+00
1.8e+00
cases:2.52%
controls:0.28%
cases:2.23%
controls:0.12%
—
—
—
—
—
—
cases:1.02%
controls:0.13%
cases:1.90%
controls:0.32%
18
19
697
6890
16
8
700
6907
—
—
—
7
9
680
6800
12
20
620
6191
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.5e+00
1.4e+00
3.0e+00
1.0e+50
—
1.6e+00
1.5e+00
cases:4.34%
controls:0.96%
cases:2.93%
controls:0.71%
cases:1.40%
controls:0.07%
cases:1.82%
controls:0.00%
—
—
cases:2.91%
controls:0.60%
cases:6.80%
controls:1.67%
31
66
684
6843
21
49
695
6866
10
5
706
6910
13
0
703
6915
—
20
41
667
6768
43
104
589
6107
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
2.4e+00
2.5e+00
—
—
—
2.1e+00
1.9e+00
cases:1.96%
controls:0.17%
cases:1.54%
controls:0.13%
—
—
—
—
—
—
cases:1.02%
controls:0.13%
cases:1.74%
controls:0.27%
14
12
701
6897
11
9
705
6906
—
—
—
7
9
680
6800
11
17
621
6194
Medical Oncology
90 [38004507]
90 [38004507]
4.2e-01
1.1e+00
1.7e+00
2.6e+00
1.3e+00
1.1e+00
1.0e+00
cases:3.50%
controls:2.32%
cases:5.03%
controls:1.69%
cases:2.23%
controls:0.43%
cases:1.12%
controls:0.09%
cases:2.25%
controls:0.59%
cases:4.08%
controls:1.34%
cases:5.06%
controls:1.93%
25
160
690
6749
36
117
680
6798
16
30
700
6885
8
6
708
6909
16
41
696
6867
28
91
659
6718
32
120
600
6091
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
39480-9 [3038515]
2.5e+00
2.2e+00
1.0e+50
1.0e+50
—
2.5e+00
1.6e+00
cases:2.80%
controls:0.23%
cases:1.68%
controls:0.19%
cases:0.70%
controls:0.00%
cases:1.68%
controls:0.00%
—
—
cases:1.89%
controls:0.16%
cases:2.85%
controls:0.58%
20
16
695
6893
12
13
704
6902
5
0
711
6915
12
0
704
6915
—
13
11
674
6798
18
36
614
6175
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
2.5e+00
2.1e+00
1.0e+50
1.0e+50
—
2.4e+00
1.7e+00
cases:2.80%
controls:0.25%
cases:1.68%
controls:0.20%
cases:0.70%
controls:0.00%
cases:1.68%
controls:0.00%
—
—
cases:2.04%
controls:0.19%
cases:3.32%
controls:0.61%
20
17
695
6892
12
14
704
6901
5
0
711
6915
12
0
704
6915
—
14
13
673
6796
21
38
611
6173
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.9e+00
2.3e+00
—
—
2.1e+00
1.9e+00
2.4e+00
cases:3.22%
controls:0.49%
cases:3.07%
controls:0.30%
—
—
—
—
cases:0.70%
controls:0.09%
cases:2.04%
controls:0.31%
cases:4.91%
controls:0.47%
23
34
692
6875
22
21
694
6894
—
—
5
6
707
6902
14
21
673
6788
31
29
601
6182
Pediatric Medicine
37 [38004477]
37 [38004477]
-1.9e-02
3.7e-01
8.5e-01
5.4e+00
1.7e+00
6.1e-01
3.0e-01
cases:14.69%
controls:14.92%
cases:10.75%
controls:7.71%
cases:4.61%
controls:2.02%
cases:15.78%
controls:0.09%
cases:10.25%
controls:2.04%
cases:12.08%
controls:6.95%
cases:14.24%
controls:10.92%
105
1031
610
5878
77
533
639
6382
33
140
683
6775
113
6
603
6909
73
141
639
6767
83
473
604
6336
90
678
542
5533
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
33863-2 [3030366]
1.4e+00
1.7e+00
2.5e+00
—
—
1.5e+00
1.4e+00
cases:1.40%
controls:0.33%
cases:1.68%
controls:0.30%
cases:0.84%
controls:0.07%
—
—
—
—
cases:1.46%
controls:0.34%
cases:3.48%
controls:0.87%
10
23
705
6886
12
21
704
6894
6
5
710
6910
—
—
10
23
677
6786
22
54
610
6157
Emergency Room Visit
ER [9203]
ER [9203]
5.4e-01
9.0e-01
2.6e+00
—
2.7e+00
1.1e+00
5.5e-01
cases:38.18%
controls:26.39%
cases:19.83%
controls:9.17%
cases:12.71%
controls:1.03%
—
—
cases:12.22%
controls:0.96%
cases:21.11%
controls:8.22%
cases:38.13%
controls:26.23%
273
1823
442
5086
142
634
574
6281
91
71
625
6844
—
87
66
625
6842
145
560
542
6249
241
1629
391
4582
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
6.5e-01
1.1e+00
2.1e+00
1.0e+50
3.3e+00
1.2e+00
7.0e-01
cases:4.62%
controls:2.48%
cases:3.91%
controls:1.40%
cases:1.54%
controls:0.19%
cases:1.12%
controls:0.00%
cases:3.09%
controls:0.12%
cases:3.93%
controls:1.23%
cases:6.49%
controls:3.33%
33
171
682
6738
28
97
688
6818
11
13
705
6902
8
0
708
6915
22
8
690
6900
27
84
660
6725
41
207
591
6004
Pauciarticular juvenile arthritis
M08.4 [45582020]
M08.4 [45582020]
2.7e+00
2.6e+00
—
—
—
—
2.9e+00
cases:1.12%
controls:0.07%
cases:0.98%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.08%
8
5
707
6904
7
5
709
6910
—
—
—
—
9
5
623
6206
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
7.9e-01
1.3e+00
1.9e+00
—
2.2e+00
1.7e+00
1.0e+00
cases:2.80%
controls:1.29%
cases:3.07%
controls:0.90%
cases:1.26%
controls:0.19%
—
—
cases:1.83%
controls:0.20%
cases:3.49%
controls:0.63%
cases:4.43%
controls:1.64%
20
89
695
6820
22
62
694
6853
9
13
707
6902
—
13
14
699
6894
24
43
663
6766
28
102
604
6109
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
7.0e-02
3.3e-01
1.4e+00
4.6e+00
1.8e+00
3.2e-01
2.1e-01
cases:21.12%
controls:19.97%
cases:20.11%
controls:15.31%
cases:11.45%
controls:3.22%
cases:14.11%
controls:0.16%
cases:15.59%
controls:2.94%
cases:19.36%
controls:14.88%
cases:27.85%
controls:23.88%
151
1380
564
5529
144
1059
572
5856
82
223
634
6692
101
11
615
6904
111
203
601
6705
133
1013
554
5796
176
1483
456
4728
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.2e-01
3.1e-01
1.3e+00
4.5e+00
1.7e+00
4.1e-01
2.5e-01
cases:16.92%
controls:15.26%
cases:16.62%
controls:12.75%
cases:10.61%
controls:3.01%
cases:12.01%
controls:0.14%
cases:13.48%
controls:2.74%
cases:17.32%
controls:12.18%
cases:24.21%
controls:19.93%
121
1054
594
5855
119
882
597
6033
76
208
640
6707
86
10
630
6905
96
189
616
6719
119
829
568
5980
153
1238
479
4973
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
6.2e-02
3.3e-01
1.3e+00
4.6e+00
1.8e+00
3.1e-01
2.1e-01
cases:21.12%
controls:20.10%
cases:20.25%
controls:15.44%
cases:11.45%
controls:3.34%
cases:13.27%
controls:0.16%
cases:15.73%
controls:3.01%
cases:19.51%
controls:15.14%
cases:28.01%
controls:24.02%
151
1389
564
5520
145
1068
571
5847
82
231
634
6684
95
11
621
6904
112
208
600
6700
134
1031
553
5778
177
1492
455
4719
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
6.8e-01
1.2e+00
2.1e+00
1.0e+50
2.3e+00
1.5e+00
9.8e-01
cases:3.50%
controls:1.79%
cases:2.79%
controls:0.90%
cases:1.54%
controls:0.19%
cases:1.12%
controls:0.00%
cases:0.84%
controls:0.09%
cases:2.77%
controls:0.65%
cases:4.59%
controls:1.77%
25
124
690
6785
20
62
696
6853
11
13
705
6902
8
0
708
6915
6
6
706
6902
19
44
668
6765
29
110
603
6101
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
7.0e-01
1.1e+00
1.9e+00
1.0e+50
2.5e+00
1.1e+00
6.6e-01
cases:7.27%
controls:3.73%
cases:4.05%
controls:1.39%
cases:1.26%
controls:0.19%
cases:1.40%
controls:0.00%
cases:2.11%
controls:0.17%
cases:3.78%
controls:1.32%
cases:7.75%
controls:4.15%
52
258
663
6651
29
96
687
6819
9
13
707
6902
10
0
706
6915
15
12
697
6896
26
90
661
6719
49
258
583
5953
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
NK6QA [2001308500]
1.9e+00
2.0e+00
—
—
—
1.9e+00
1.9e+00
cases:2.38%
controls:0.35%
cases:1.40%
controls:0.19%
—
—
—
—
—
—
cases:1.16%
controls:0.18%
cases:3.48%
controls:0.52%
17
24
698
6885
10
13
706
6902
—
—
—
8
12
679
6797
22
32
610
6179
Glomerular filtration rate (GFR) Isotope mesurement
KA1MN [2001305637]
KA1MN [2001305637]
2.6e+00
—
—
—
—
2.8e+00
2.4e+00
cases:1.12%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.07%
cases:1.42%
controls:0.13%
8
6
707
6903
—
—
—
—
8
5
679
6804
9
8
623
6203
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.0e-01
3.7e-01
1.3e+00
4.3e+00
1.7e+00
3.3e-01
3.0e-01
cases:21.12%
controls:19.48%
cases:17.74%
controls:12.96%
cases:9.36%
controls:2.68%
cases:10.61%
controls:0.16%
cases:11.94%
controls:2.32%
cases:16.01%
controls:12.04%
cases:28.16%
controls:22.51%
151
1346
564
5563
127
896
589
6019
67
185
649
6730
76
11
640
6904
85
160
627
6748
110
820
577
5989
178
1398
454
4813
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
1.0e+00
1.4e+00
—
—
2.9e+00
1.4e+00
1.0e+00
cases:2.66%
controls:1.00%
cases:2.09%
controls:0.52%
—
—
—
—
cases:1.26%
controls:0.07%
cases:1.89%
controls:0.46%
cases:3.80%
controls:1.43%
19
69
696
6840
15
36
701
6879
—
—
9
5
703
6903
13
31
674
6778
24
89
608
6122
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
5.3e-01
9.8e-01
2.3e+00
—
2.1e+00
1.3e+00
1.0e+00
cases:3.64%
controls:2.17%
cases:2.51%
controls:0.95%
cases:0.84%
controls:0.09%
—
—
cases:0.84%
controls:0.10%
cases:2.77%
controls:0.75%
cases:6.65%
controls:2.56%
26
150
689
6759
18
66
698
6849
6
6
710
6909
—
6
7
706
6901
19
51
668
6758
42
159
590
6052
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
2.0e+00
2.0e+00
—
—
—
2.2e+00
1.5e+00
cases:1.82%
controls:0.25%
cases:0.98%
controls:0.13%
—
—
—
—
—
—
cases:1.16%
controls:0.13%
cases:1.58%
controls:0.37%
13
17
702
6892
7
9
709
6906
—
—
—
8
9
679
6800
10
23
622
6188
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
2.0e+00
2.0e+00
—
—
—
2.2e+00
1.5e+00
cases:1.82%
controls:0.25%
cases:0.98%
controls:0.13%
—
—
—
—
—
—
cases:1.16%
controls:0.13%
cases:1.58%
controls:0.37%
13
17
702
6892
7
9
709
6906
—
—
—
8
9
679
6800
10
23
622
6188
Inpatient Hospital
21 [8717]
21 [8717]
3.9e-01
8.5e-01
2.1e+00
—
2.6e+00
1.1e+00
6.4e-01
cases:37.06%
controls:28.41%
cases:19.97%
controls:9.62%
cases:8.94%
controls:1.24%
—
—
cases:14.89%
controls:1.27%
cases:21.69%
controls:8.36%
cases:35.92%
controls:22.77%
265
1963
450
4946
143
665
573
6250
64
86
652
6829
—
106
88
606
6820
149
569
538
6240
227
1414
405
4797
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
2.3e-01
1.4e+00
2.5e+00
—
2.5e+00
1.1e+00
1.3e+00
cases:1.68%
controls:1.33%
cases:2.09%
controls:0.52%
cases:0.84%
controls:0.07%
—
—
cases:0.84%
controls:0.07%
cases:1.46%
controls:0.51%
cases:4.59%
controls:1.27%
12
92
703
6817
15
36
701
6879
6
5
710
6910
—
6
5
706
6903
10
35
677
6774
29
79
603
6132
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
2.2e+00
2.0e+00
—
1.0e+50
—
2.2e+00
1.2e+00
cases:3.36%
controls:0.39%
cases:2.23%
controls:0.30%
—
—
cases:1.82%
controls:0.00%
—
—
cases:2.18%
controls:0.25%
cases:3.01%
controls:0.90%
24
27
691
6882
16
21
700
6894
—
13
0
703
6915
—
15
17
672
6792
19
56
613
6155
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
2.2e+00
1.9e+00
—
1.0e+50
—
2.0e+00
1.4e+00
cases:3.36%
controls:0.38%
cases:2.09%
controls:0.30%
—
—
cases:1.82%
controls:0.00%
—
—
cases:2.18%
controls:0.29%
cases:3.48%
controls:0.92%
24
26
691
6883
15
21
701
6894
—
13
0
703
6915
—
15
20
672
6789
22
57
610
6154
Liver transplant status
Z94.4 [45566478]
Z94.4 [45566478]
—
2.5e+00
—
—
—
2.6e+00
2.4e+00
—
—
cases:0.84%
controls:0.07%
—
—
—
—
—
—
cases:1.02%
controls:0.07%
cases:1.11%
controls:0.10%
—
6
5
710
6910
—
—
—
7
5
680
6804
7
6
625
6205
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
-2.4e-02
3.2e-01
1.3e+00
4.6e+00
1.6e+00
3.5e-01
1.7e-01
cases:14.41%
controls:14.71%
cases:16.20%
controls:12.34%
cases:9.64%
controls:2.73%
cases:8.80%
controls:0.10%
cases:12.08%
controls:2.58%
cases:16.74%
controls:12.45%
cases:21.84%
controls:19.00%
103
1016
612
5893
116
853
600
6062
69
189
647
6726
63
7
653
6908
86
178
626
6730
115
848
572
5961
138
1180
494
5031
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
4.5e-01
9.7e-01
1.9e+00
—
2.6e+00
8.9e-01
7.6e-01
cases:9.93%
controls:6.57%
cases:9.92%
controls:4.02%
cases:3.77%
controls:0.59%
—
—
cases:7.72%
controls:0.64%
cases:8.59%
controls:3.73%
cases:15.82%
controls:8.11%
71
454
644
6455
71
278
645
6637
27
41
689
6874
—
55
44
657
6864
59
254
628
6555
100
504
532
5707
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
4.5e-01
1.0e+00
1.9e+00
1.0e+50
2.2e+00
1.1e+00
8.4e-01
cases:10.07%
controls:6.64%
cases:9.22%
controls:3.53%
cases:4.47%
controls:0.69%
cases:1.96%
controls:0.00%
cases:6.18%
controls:0.74%
cases:9.90%
controls:3.48%
cases:15.82%
controls:7.52%
72
459
643
6450
66
244
650
6671
32
48
684
6867
14
0
702
6915
44
51
668
6857
68
237
619
6572
100
467
532
5744
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
4.5e-01
9.7e-01
1.9e+00
—
2.5e+00
8.9e-01
7.6e-01
cases:9.93%
controls:6.54%
cases:9.92%
controls:4.02%
cases:3.77%
controls:0.59%
—
—
cases:7.58%
controls:0.64%
cases:8.59%
controls:3.70%
cases:15.82%
controls:8.07%
71
452
644
6457
71
278
645
6637
27
41
689
6874
—
54
44
658
6864
59
252
628
6557
100
501
532
5710
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
4.6e-01
9.7e-01
1.8e+00
—
2.5e+00
9.0e-01
7.7e-01
cases:9.93%
controls:6.53%
cases:9.92%
controls:4.02%
cases:3.63%
controls:0.59%
—
—
cases:7.58%
controls:0.64%
cases:8.73%
controls:3.73%
cases:15.98%
controls:8.10%
71
451
644
6458
71
278
645
6637
26
41
690
6874
—
54
44
658
6864
60
254
627
6555
101
503
531
5708
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
5.7e-01
1.2e+00
2.0e+00
—
1.5e+00
1.2e+00
9.4e-01
cases:6.15%
controls:3.56%
cases:4.75%
controls:1.45%
cases:1.40%
controls:0.19%
—
—
cases:1.26%
controls:0.28%
cases:3.78%
controls:1.17%
cases:8.86%
controls:3.65%
44
246
671
6663
34
100
682
6815
10
13
706
6902
—
9
19
703
6889
26
80
661
6729
56
227
576
5984
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
7.4e-02
3.0e-01
1.3e+00
4.5e+00
1.7e+00
2.5e-01
1.7e-01
cases:22.80%
controls:21.52%
cases:22.07%
controls:17.40%
cases:12.57%
controls:3.88%
cases:14.11%
controls:0.19%
cases:16.71%
controls:3.62%
cases:20.96%
controls:17.17%
cases:29.27%
controls:25.89%
163
1487
552
5422
158
1203
558
5712
90
268
626
6647
101
13
615
6902
119
250
593
6658
144
1169
543
5640
185
1608
447
4603
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
5.4e-01
1.0e+00
1.7e+00
1.0e+50
2.1e+00
1.2e+00
6.6e-01
cases:8.39%
controls:5.07%
cases:6.28%
controls:2.34%
cases:1.96%
controls:0.35%
cases:2.37%
controls:0.00%
cases:2.25%
controls:0.28%
cases:6.11%
controls:1.84%
cases:9.02%
controls:4.86%
60
350
655
6559
45
162
671
6753
14
24
702
6891
17
0
699
6915
16
19
696
6889
42
125
645
6684
57
302
575
5909
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.6e-01
9.6e-01
1.7e+00
—
2.2e+00
1.0e+00
8.5e-01
cases:10.77%
controls:7.11%
cases:9.64%
controls:3.90%
cases:3.49%
controls:0.68%
—
—
cases:5.34%
controls:0.61%
cases:9.75%
controls:3.70%
cases:16.30%
controls:7.68%
77
491
638
6418
69
270
647
6645
25
47
691
6868
—
38
42
674
6866
67
252
620
6557
103
477
529
5734
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.3e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.4e-01
1.7e-01
cases:23.64%
controls:23.23%
cases:23.18%
controls:19.48%
cases:13.55%
controls:4.50%
cases:16.48%
controls:0.26%
cases:18.54%
controls:4.27%
cases:23.00%
controls:19.06%
cases:33.39%
controls:29.79%
169
1605
546
5304
166
1347
550
5568
97
311
619
6604
118
18
598
6897
132
295
580
6613
158
1298
529
5511
211
1850
421
4361
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
1.0e+00
1.7e+00
1.5e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:3.64%
controls:1.33%
cases:4.33%
controls:0.82%
cases:0.70%
controls:0.16%
—
—
cases:1.26%
controls:0.17%
cases:3.64%
controls:0.98%
cases:5.70%
controls:1.98%
26
92
689
6817
31
57
685
6858
5
11
711
6904
—
9
12
703
6896
25
67
662
6742
36
123
596
6088
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.5e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.3e-01
1.8e-01
cases:23.64%
controls:23.19%
cases:23.18%
controls:19.45%
cases:13.55%
controls:4.48%
cases:16.34%
controls:0.26%
cases:18.40%
controls:4.24%
cases:22.85%
controls:19.00%
cases:33.54%
controls:29.75%
169
1602
546
5307
166
1345
550
5570
97
310
619
6605
117
18
599
6897
131
293
581
6615
157
1294
530
5515
212
1848
420
4363
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.5e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.4e-01
1.6e-01
cases:23.64%
controls:23.19%
cases:23.18%
controls:19.45%
cases:13.55%
controls:4.47%
cases:16.20%
controls:0.26%
cases:18.40%
controls:4.23%
cases:22.85%
controls:18.97%
cases:33.23%
controls:29.72%
169
1602
546
5307
166
1345
550
5570
97
309
619
6606
116
18
600
6897
131
292
581
6616
157
1292
530
5517
210
1846
422
4365
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.5e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.3e-01
1.7e-01
cases:23.64%
controls:23.19%
cases:23.18%
controls:19.45%
cases:13.55%
controls:4.47%
cases:16.20%
controls:0.26%
cases:18.40%
controls:4.24%
cases:22.85%
controls:18.99%
cases:33.23%
controls:29.67%
169
1602
546
5307
166
1345
550
5570
97
309
619
6606
116
18
600
6897
131
293
581
6615
157
1293
530
5516
210
1843
422
4368
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.0e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.2e-01
1.6e-01
cases:23.50%
controls:23.14%
cases:23.18%
controls:19.42%
cases:13.55%
controls:4.48%
cases:16.20%
controls:0.26%
cases:18.40%
controls:4.24%
cases:22.56%
controls:19.02%
cases:33.07%
controls:29.67%
168
1599
547
5310
166
1343
550
5572
97
310
619
6605
116
18
600
6897
131
293
581
6615
155
1295
532
5514
209
1843
423
4368
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.5e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.3e-01
1.6e-01
cases:23.64%
controls:23.19%
cases:23.18%
controls:19.44%
cases:13.55%
controls:4.47%
cases:16.20%
controls:0.26%
cases:18.40%
controls:4.26%
cases:22.85%
controls:19.00%
cases:33.23%
controls:29.71%
169
1602
546
5307
166
1344
550
5571
97
309
619
6606
116
18
600
6897
131
294
581
6614
157
1294
530
5515
210
1845
422
4366
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.5e-02
2.2e-01
1.2e+00
4.3e+00
1.6e+00
2.3e-01
1.6e-01
cases:23.64%
controls:23.19%
cases:23.18%
controls:19.46%
cases:13.55%
controls:4.50%
cases:16.20%
controls:0.26%
cases:18.40%
controls:4.24%
cases:22.85%
controls:19.02%
cases:33.23%
controls:29.72%
169
1602
546
5307
166
1346
550
5569
97
311
619
6604
116
18
600
6897
131
293
581
6615
157
1295
530
5514
210
1846
422
4365
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
1.4e+00
2.0e+00
—
—
—
2.1e+00
1.7e+00
cases:2.10%
controls:0.55%
cases:1.12%
controls:0.16%
—
—
—
—
—
—
cases:1.16%
controls:0.15%
cases:2.06%
controls:0.39%
15
38
700
6871
8
11
708
6904
—
—
—
8
10
679
6799
13
24
619
6187
Potassium [Moles/volume] in Venous blood
39789-3 [3041354]
39789-3 [3041354]
2.4e+00
2.1e+00
—
1.0e+50
—
2.5e+00
—
cases:2.24%
controls:0.20%
cases:0.98%
controls:0.12%
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.87%
controls:0.07%
—
—
16
14
699
6895
7
8
709
6907
—
5
0
711
6915
—
6
5
681
6804
—
Chloride [Moles/volume] in Venous blood
41649-5 [3035285]
41649-5 [3035285]
2.4e+00
2.1e+00
—
1.0e+50
—
2.5e+00
—
cases:2.24%
controls:0.20%
cases:0.98%
controls:0.12%
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.87%
controls:0.07%
—
—
16
14
699
6895
7
8
709
6907
—
5
0
711
6915
—
6
5
681
6804
—
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
41645-3 [3033705]
2.4e+00
2.1e+00
—
1.0e+50
—
2.5e+00
—
cases:2.24%
controls:0.20%
cases:0.98%
controls:0.12%
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.87%
controls:0.07%
—
—
16
14
699
6895
7
8
709
6907
—
5
0
711
6915
—
6
5
681
6804
—
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
4.2e-01
9.6e-01
1.9e+00
—
2.5e+00
8.9e-01
7.6e-01
cases:9.79%
controls:6.63%
cases:9.78%
controls:3.99%
cases:3.91%
controls:0.59%
—
—
cases:7.72%
controls:0.68%
cases:8.73%
controls:3.77%
cases:16.14%
controls:8.24%
70
458
645
6451
70
276
646
6639
28
41
688
6874
—
55
47
657
6861
60
257
627
6552
102
512
530
5699
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.4e-01
1.3e+00
1.3e+00
—
1.7e+00
1.2e+00
7.5e-01
cases:12.87%
controls:6.59%
cases:9.36%
controls:2.70%
cases:2.23%
controls:0.59%
—
—
cases:2.81%
controls:0.52%
cases:8.01%
controls:2.64%
cases:12.82%
controls:6.49%
92
455
623
6454
67
187
649
6728
16
41
700
6874
—
20
36
692
6872
55
180
632
6629
81
403
551
5808
Outpatient Hospital
22 [8756]
22 [8756]
3.4e-01
7.7e-01
1.8e+00
—
2.0e+00
1.4e+00
7.6e-01
cases:26.71%
controls:20.57%
cases:13.13%
controls:6.55%
cases:4.89%
controls:0.88%
—
—
cases:5.62%
controls:0.80%
cases:17.03%
controls:4.89%
cases:27.69%
controls:15.18%
191
1421
524
5488
94
453
622
6462
35
61
681
6854
—
40
55
672
6853
117
333
570
6476
175
943
457
5268
Neurology
13 [38004458]
13 [38004458]
5.0e-01
6.6e-01
1.9e+00
—
2.0e+00
1.4e+00
6.1e-01
cases:9.79%
controls:6.19%
cases:5.03%
controls:2.68%
cases:3.21%
controls:0.51%
—
—
cases:3.51%
controls:0.49%
cases:9.61%
controls:2.63%
cases:10.60%
controls:6.05%
70
428
645
6481
36
185
680
6730
23
35
693
6880
—
25
34
687
6874
66
179
621
6630
67
376
565
5835
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
4.1e-01
9.5e-01
1.9e+00
—
2.6e+00
8.6e-01
6.9e-01
cases:9.93%
controls:6.83%
cases:9.92%
controls:4.09%
cases:4.05%
controls:0.61%
—
—
cases:8.01%
controls:0.67%
cases:8.73%
controls:3.88%
cases:15.82%
controls:8.58%
71
472
644
6437
71
283
645
6632
29
42
687
6873
—
57
46
655
6862
60
264
627
6545
100
533
532
5678
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
7.3e-01
1.3e+00
1.3e+00
—
1.7e+00
1.2e+00
7.5e-01
cases:12.87%
controls:6.61%
cases:9.36%
controls:2.72%
cases:2.23%
controls:0.59%
—
—
cases:2.81%
controls:0.52%
cases:8.01%
controls:2.66%
cases:12.82%
controls:6.50%
92
457
623
6452
67
188
649
6727
16
41
700
6874
—
20
36
692
6872
55
181
632
6628
81
404
551
5807
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
5.3e-01
7.1e-01
1.8e+00
—
1.9e+00
1.3e+00
7.1e-01
cases:8.81%
controls:5.37%
cases:5.03%
controls:2.55%
cases:1.82%
controls:0.30%
—
—
cases:3.23%
controls:0.48%
cases:6.40%
controls:1.82%
cases:11.23%
controls:5.86%
63
371
652
6538
36
176
680
6739
13
21
703
6894
—
23
33
689
6875
44
124
643
6685
71
364
561
5847
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
2.1e+00
1.8e+00
—
1.0e+50
—
2.0e+00
1.2e+00
cases:3.50%
controls:0.46%
cases:2.09%
controls:0.36%
—
—
cases:1.96%
controls:0.00%
—
—
cases:2.33%
controls:0.34%
cases:3.32%
controls:1.01%
25
32
690
6877
15
25
701
6890
—
14
0
702
6915
—
16
23
671
6786
21
63
611
6148
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.4e-01
7.4e-01
2.3e+00
1.0e+50
1.9e+00
1.0e+00
5.3e-01
cases:11.75%
controls:7.92%
cases:8.24%
controls:4.12%
cases:5.03%
controls:0.52%
cases:4.61%
controls:0.00%
cases:3.79%
controls:0.58%
cases:9.46%
controls:3.61%
cases:14.40%
controls:9.02%
84
547
631
6362
59
285
657
6630
36
36
680
6879
33
0
683
6915
27
40
685
6868
65
246
622
6563
91
560
541
5651
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
5.5e-02
2.2e-01
1.1e+00
4.3e+00
1.5e+00
2.7e-01
9.8e-02
cases:17.90%
controls:17.11%
cases:15.92%
controls:13.25%
cases:9.08%
controls:3.20%
cases:10.75%
controls:0.16%
cases:12.08%
controls:2.95%
cases:16.16%
controls:12.87%
cases:23.42%
controls:21.70%
128
1182
587
5727
114
916
602
5999
65
221
651
6694
77
11
639
6904
86
204
626
6704
111
876
576
5933
148
1348
484
4863
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
7.6e-01
1.4e+00
2.3e+00
1.0e+50
1.5e+00
1.5e+00
1.0e+00
cases:10.49%
controls:5.18%
cases:6.98%
controls:1.91%
cases:2.09%
controls:0.22%
cases:5.59%
controls:0.00%
cases:0.98%
controls:0.22%
cases:7.13%
controls:1.69%
cases:12.82%
controls:4.96%
75
358
640
6551
50
132
666
6783
15
15
701
6900
40
0
676
6915
7
15
705
6893
49
115
638
6694
81
308
551
5903
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
5.3e-01
9.0e-01
1.7e+00
—
2.0e+00
1.1e+00
6.5e-01
cases:13.85%
controls:8.61%
cases:8.38%
controls:3.59%
cases:2.51%
controls:0.49%
—
—
cases:4.49%
controls:0.62%
cases:9.61%
controls:3.32%
cases:15.19%
controls:8.57%
99
595
616
6314
60
248
656
6667
18
34
698
6881
—
32
43
680
6865
66
226
621
6583
96
532
536
5679
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
2.4e-01
5.6e-01
2.5e+00
1.0e+50
2.6e+00
1.0e+00
6.8e-01
cases:4.34%
controls:3.44%
cases:2.65%
controls:1.53%
cases:1.82%
controls:0.14%
cases:0.84%
controls:0.00%
cases:1.40%
controls:0.10%
cases:3.64%
controls:1.35%
cases:7.12%
controls:3.75%
31
238
684
6671
19
106
697
6809
13
10
703
6905
6
0
710
6915
10
7
702
6901
25
92
662
6717
45
233
587
5978
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
4.1e-01
8.8e-01
1.9e+00
—
2.5e+00
8.6e-01
7.1e-01
cases:10.63%
controls:7.34%
cases:10.06%
controls:4.44%
cases:4.05%
controls:0.65%
—
—
cases:8.29%
controls:0.77%
cases:9.32%
controls:4.17%
cases:16.61%
controls:8.89%
76
507
639
6402
72
307
644
6608
29
45
687
6870
—
59
53
653
6855
64
284
623
6525
105
552
527
5659
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
4.3e-01
9.0e-01
1.8e+00
—
2.5e+00
8.8e-01
7.4e-01
cases:10.35%
controls:6.99%
cases:9.92%
controls:4.30%
cases:3.49%
controls:0.62%
—
—
cases:8.01%
controls:0.71%
cases:9.02%
controls:3.97%
cases:16.30%
controls:8.52%
74
483
641
6426
71
297
645
6618
25
43
691
6872
—
57
49
655
6859
62
270
625
6539
103
529
529
5682
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.1e+00
1.6e+00
1.3e+00
—
1.9e+00
1.3e+00
9.1e-01
cases:4.76%
controls:1.66%
cases:4.33%
controls:0.91%
cases:0.70%
controls:0.19%
—
—
cases:1.26%
controls:0.19%
cases:3.64%
controls:1.06%
cases:5.85%
controls:2.45%
34
115
681
6794
31
63
685
6852
5
13
711
6902
—
9
13
703
6895
25
72
662
6737
37
152
595
6059
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
4.4e-01
9.1e-01
1.8e+00
—
2.5e+00
8.8e-01
7.4e-01
cases:10.35%
controls:6.93%
cases:9.92%
controls:4.25%
cases:3.49%
controls:0.62%
—
—
cases:7.87%
controls:0.71%
cases:9.02%
controls:3.97%
cases:16.30%
controls:8.52%
74
479
641
6430
71
294
645
6621
25
43
691
6872
—
56
49
656
6859
62
270
625
6539
103
529
529
5682
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
4.3e-01
8.6e-01
1.7e+00
—
2.5e+00
8.5e-01
7.5e-01
cases:10.91%
controls:7.41%
cases:10.06%
controls:4.50%
cases:3.63%
controls:0.67%
—
—
cases:8.15%
controls:0.75%
cases:9.17%
controls:4.14%
cases:16.77%
controls:8.69%
78
512
637
6397
72
311
644
6604
26
46
690
6869
—
58
52
654
6856
63
282
624
6527
106
540
526
5671
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-1.7e-01
7.9e-01
1.7e+00
1.0e+50
2.4e+00
1.0e+00
7.0e-01
cases:2.94%
controls:3.46%
cases:3.77%
controls:1.75%
cases:1.54%
controls:0.29%
cases:1.68%
controls:0.00%
cases:2.25%
controls:0.20%
cases:4.22%
controls:1.53%
cases:6.33%
controls:3.24%
21
239
694
6670
27
121
689
6794
11
20
705
6895
12
0
704
6915
16
14
696
6894
29
104
658
6705
40
201
592
6010
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
9.9e-01
1.6e+00
1.4e+00
—
1.8e+00
1.3e+00
9.4e-01
cases:3.92%
controls:1.49%
cases:4.19%
controls:0.88%
cases:0.70%
controls:0.17%
—
—
cases:1.12%
controls:0.19%
cases:3.49%
controls:0.98%
cases:5.54%
controls:2.24%
28
103
687
6806
30
61
686
6854
5
12
711
6903
—
8
13
704
6895
24
67
663
6742
35
139
597
6072
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
7.6e-01
1.5e+00
—
—
2.4e+00
1.5e+00
1.2e+00
cases:2.24%
controls:1.06%
cases:2.09%
controls:0.49%
—
—
—
—
cases:1.12%
controls:0.10%
cases:2.33%
controls:0.53%
cases:3.80%
controls:1.18%
16
73
699
6836
15
34
701
6881
—
—
8
7
704
6901
16
36
671
6773
24
73
608
6138
valaciclovir; oral
J05AB11 [21603137]
J05AB11 [21603137]
1.0e+00
1.4e+00
—
1.0e+50
—
2.8e+00
1.3e+00
cases:2.52%
controls:0.94%
cases:1.40%
controls:0.33%
—
—
cases:5.31%
controls:0.00%
—
—
cases:5.68%
controls:0.35%
cases:4.11%
controls:1.16%
18
65
697
6844
10
23
706
6892
—
38
0
678
6915
—
39
24
648
6785
26
72
606
6139
Pulmonary Disease
29 [38004472]
29 [38004472]
5.6e-01
9.7e-01
1.6e+00
—
1.4e+00
1.1e+00
9.9e-01
cases:8.39%
controls:4.96%
cases:6.15%
controls:2.42%
cases:1.82%
controls:0.39%
—
—
cases:1.83%
controls:0.48%
cases:6.84%
controls:2.38%
cases:12.50%
controls:5.06%
60
343
655
6566
44
167
672
6748
13
27
703
6888
—
13
33
699
6875
47
162
640
6647
79
314
553
5897
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.3e-01
7.2e-01
1.9e+00
—
2.5e+00
5.3e-01
5.2e-01
cases:30.07%
controls:23.69%
cases:13.69%
controls:7.14%
cases:5.03%
controls:0.80%
—
—
cases:8.71%
controls:0.78%
cases:12.08%
controls:7.50%
cases:35.28%
controls:24.54%
215
1637
500
5272
98
494
618
6421
36
55
680
6860
—
62
54
650
6854
83
511
604
6298
223
1524
409
4687
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
57778-3 [40760888]
1.6e+00
2.1e+00
—
—
1.0e+50
2.2e+00
2.2e+00
cases:1.12%
controls:0.23%
cases:1.26%
controls:0.16%
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.16%
controls:0.13%
cases:1.58%
controls:0.18%
8
16
707
6893
9
11
707
6904
—
—
5
0
707
6908
8
9
679
6800
10
11
622
6200
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
7.3e-01
1.4e+00
2.7e+00
1.0e+50
—
1.4e+00
8.6e-01
cases:2.52%
controls:1.23%
cases:2.65%
controls:0.65%
cases:1.54%
controls:0.10%
cases:1.26%
controls:0.00%
—
—
cases:2.18%
controls:0.53%
cases:5.22%
controls:2.27%
18
85
697
6824
19
45
697
6870
11
7
705
6908
9
0
707
6915
—
15
36
672
6773
33
141
599
6070
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
4533-6 [3024403]
2.1e+00
2.4e+00
—
—
—
—
1.9e+00
cases:1.40%
controls:0.17%
cases:1.12%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.19%
10
12
705
6897
8
7
708
6908
—
—
—
—
8
12
624
6199
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
4.7e-01
1.5e+00
—
—
2.5e+00
1.3e+00
1.0e+00
cases:4.06%
controls:2.56%
cases:3.07%
controls:0.72%
—
—
—
—
cases:1.40%
controls:0.12%
cases:2.33%
controls:0.62%
cases:7.75%
controls:2.90%
29
177
686
6732
22
50
694
6865
—
—
10
8
702
6900
16
42
671
6767
49
180
583
6031
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.9e-01
1.1e+00
1.7e+00
—
1.8e+00
9.5e-01
7.4e-01
cases:8.25%
controls:5.72%
cases:8.52%
controls:3.12%
cases:2.79%
controls:0.51%
—
—
cases:3.79%
controls:0.62%
cases:7.28%
controls:2.95%
cases:12.66%
controls:6.44%
59
395
656
6514
61
216
655
6699
20
35
696
6880
—
27
43
685
6865
50
201
637
6608
80
400
552
5811
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
6.8e-01
1.9e+00
—
—
—
2.9e+00
1.5e+00
cases:1.82%
controls:0.93%
cases:1.40%
controls:0.22%
—
—
—
—
—
—
cases:1.31%
controls:0.07%
cases:1.42%
controls:0.31%
13
64
702
6845
10
15
706
6900
—
—
—
9
5
678
6804
9
19
623
6192
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
4.0e-01
7.5e-01
1.8e+00
—
2.3e+00
8.0e-01
6.4e-01
cases:6.29%
controls:4.33%
cases:5.87%
controls:2.85%
cases:2.37%
controls:0.40%
—
—
cases:4.92%
controls:0.51%
cases:5.97%
controls:2.78%
cases:10.60%
controls:5.86%
45
299
670
6610
42
197
674
6718
17
28
699
6887
—
35
35
677
6873
41
189
646
6620
67
364
565
5847
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.3e-01
8.2e-01
2.0e+00
—
2.1e+00
7.6e-01
5.6e-01
cases:4.76%
controls:2.85%
cases:4.47%
controls:2.01%
cases:2.51%
controls:0.35%
—
—
cases:1.69%
controls:0.20%
cases:4.37%
controls:2.09%
cases:8.54%
controls:5.06%
34
197
681
6712
32
139
684
6776
18
24
698
6891
—
12
14
700
6894
30
142
657
6667
54
314
578
5897
Outpatient Visit
OP [9202]
OP [9202]
2.4e-01
4.5e-01
7.6e-01
3.2e+00
1.0e+00
5.5e-01
3.3e-01
cases:61.82%
controls:55.98%
cases:51.26%
controls:40.07%
cases:18.30%
controls:9.50%
cases:6.15%
controls:0.27%
cases:21.49%
controls:9.15%
cases:53.57%
controls:39.87%
cases:70.57%
controls:63.39%
442
3868
273
3041
367
2771
349
4144
131
657
585
6258
44
19
672
6896
153
632
559
6276
368
2715
319
4094
446
3937
186
2274
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
1.6e+00
2.4e+00
—
—
—
—
2.1e+00
cases:1.26%
controls:0.25%
cases:0.98%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.24%
9
17
706
6892
7
6
709
6909
—
—
—
—
12
15
620
6196
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.5e-02
1.2e-01
9.0e-01
3.9e+00
1.3e+00
7.8e-02
6.8e-02
cases:25.31%
controls:25.04%
cases:25.70%
controls:23.54%
cases:16.76%
controls:7.55%
cases:19.27%
controls:0.46%
cases:21.63%
controls:7.27%
cases:25.47%
controls:24.03%
cases:35.13%
controls:33.60%
181
1730
534
5179
184
1628
532
5287
120
522
596
6393
138
32
578
6883
154
502
558
6406
175
1636
512
5173
222
2087
410
4124
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
8.5e-01
6.7e-01
1.8e+00
1.0e+50
2.3e+00
1.0e+00
1.1e+00
cases:4.48%
controls:1.95%
cases:1.96%
controls:1.01%
cases:1.12%
controls:0.19%
cases:2.65%
controls:0.00%
cases:1.26%
controls:0.13%
cases:1.89%
controls:0.70%
cases:6.49%
controls:2.21%
32
135
683
6774
14
70
702
6845
8
13
708
6902
19
0
697
6915
9
9
703
6899
13
48
674
6761
41
137
591
6074
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
6.2e-01
7.0e-01
1.9e+00
—
2.0e+00
8.3e-01
4.6e-01
cases:6.85%
controls:3.79%
cases:4.05%
controls:2.05%
cases:1.54%
controls:0.23%
—
—
cases:1.26%
controls:0.17%
cases:4.22%
controls:1.89%
cases:7.59%
controls:4.93%
49
262
666
6647
29
142
687
6773
11
16
705
6899
—
9
12
703
6896
29
129
658
6680
48
306
584
5905
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
2.3e-01
9.5e-01
2.1e+00
1.0e+50
3.0e+00
8.8e-01
8.8e-01
cases:2.10%
controls:1.68%
cases:1.26%
controls:0.49%
cases:0.84%
controls:0.10%
cases:0.98%
controls:0.00%
cases:2.39%
controls:0.12%
cases:1.16%
controls:0.48%
cases:3.01%
controls:1.27%
15
116
700
6793
9
34
707
6881
6
7
710
6908
7
0
709
6915
17
8
695
6900
8
33
679
6776
19
79
613
6132
Infectious Disease
44 [38004484]
44 [38004484]
1.0e+00
1.8e+00
—
1.0e+50
—
2.0e+00
1.2e+00
cases:2.10%
controls:0.75%
cases:1.26%
controls:0.22%
—
—
cases:5.31%
controls:0.00%
—
—
cases:2.77%
controls:0.37%
cases:3.16%
controls:0.98%
15
52
700
6857
9
15
707
6900
—
38
0
678
6915
—
19
25
668
6784
20
61
612
6150
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
8.7e-01
2.3e+00
—
—
—
2.1e+00
1.7e+00
cases:1.82%
controls:0.77%
cases:2.09%
controls:0.22%
—
—
—
—
—
—
cases:1.60%
controls:0.21%
cases:3.64%
controls:0.71%
13
53
702
6856
15
15
701
6900
—
—
—
11
14
676
6795
23
44
609
6167
Emergency Medicine
93 [38004510]
93 [38004510]
2.3e-01
7.3e-01
2.2e+00
1.0e+50
1.9e+00
7.2e-01
4.3e-01
cases:10.21%
controls:8.32%
cases:9.22%
controls:4.66%
cases:6.15%
controls:0.71%
cases:13.83%
controls:0.00%
cases:4.07%
controls:0.62%
cases:9.02%
controls:4.63%
cases:17.72%
controls:12.28%
73
575
642
6334
66
322
650
6593
44
49
672
6866
99
0
617
6915
29
43
683
6865
62
315
625
6494
112
763
520
5448
methotrexate; oral, parenteral
L04AX03 [21603929]
L04AX03 [21603929]
8.7e-01
1.2e+00
1.5e+00
—
6.3e-01
1.2e+00
1.2e+00
cases:3.92%
controls:1.68%
cases:4.05%
controls:1.27%
cases:1.68%
controls:0.38%
—
—
cases:0.70%
controls:0.38%
cases:3.93%
controls:1.20%
cases:4.59%
controls:1.43%
28
116
687
6793
29
88
687
6827
12
26
704
6889
—
5
26
707
6882
27
82
660
6727
29
89
603
6122
methotrexate
L01BA01 [21601423]
L01BA01 [21601423]
8.7e-01
1.2e+00
1.5e+00
—
6.3e-01
1.2e+00
1.2e+00
cases:3.92%
controls:1.68%
cases:4.05%
controls:1.27%
cases:1.68%
controls:0.38%
—
—
cases:0.70%
controls:0.38%
cases:3.93%
controls:1.20%
cases:4.59%
controls:1.43%
28
116
687
6793
29
88
687
6827
12
26
704
6889
—
5
26
707
6882
27
82
660
6727
29
89
603
6122
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
3520-4 [3010375]
—
—
—
—
1.0e+50
2.9e+00
3.1e+00
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.00%
cases:1.31%
controls:0.07%
cases:2.06%
controls:0.10%
—
—
—
—
8
0
704
6908
9
5
678
6804
13
6
619
6205
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
8.8e-01
2.1e+00
—
—
—
2.0e+00
1.7e+00
cases:2.38%
controls:1.00%
cases:3.35%
controls:0.40%
—
—
—
—
—
—
cases:2.77%
controls:0.38%
cases:5.38%
controls:0.98%
17
69
698
6840
24
28
692
6887
—
—
—
19
26
668
6783
34
61
598
6150
EKG study
11524-6 [3013512]
11524-6 [3013512]
8.7e-01
9.5e-01
1.5e+00
—
1.6e+00
8.8e-01
3.4e-01
cases:9.37%
controls:4.17%
cases:5.87%
controls:2.34%
cases:1.54%
controls:0.33%
—
—
cases:1.54%
controls:0.30%
cases:5.24%
controls:2.23%
cases:6.96%
controls:5.04%
67
288
648
6621
42
162
674
6753
11
23
705
6892
—
11
21
701
6887
36
152
651
6657
44
313
588
5898
Inpatient Visit
IP [9201]
IP [9201]
1.4e-01
7.2e-01
1.6e+00
—
2.3e+00
6.9e-01
6.0e-01
cases:10.77%
controls:9.48%
cases:6.42%
controls:3.22%
cases:2.37%
controls:0.51%
—
—
cases:4.07%
controls:0.43%
cases:5.09%
controls:2.61%
cases:9.81%
controls:5.64%
77
655
638
6254
46
223
670
6692
17
35
699
6880
—
29
30
683
6878
35
178
652
6631
62
350
570
5861
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.4e+00
1.8e+00
—
—
—
1.7e+00
9.2e-01
cases:2.66%
controls:0.68%
cases:1.68%
controls:0.27%
—
—
—
—
—
—
cases:1.75%
controls:0.32%
cases:3.01%
controls:1.22%
19
47
696
6862
12
19
704
6896
—
—
—
12
22
675
6787
19
76
613
6135
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
1.2e-01
7.6e-01
1.6e+00
—
2.1e+00
7.8e-01
6.2e-01
cases:4.20%
controls:3.73%
cases:4.33%
controls:2.08%
cases:2.23%
controls:0.46%
—
—
cases:3.65%
controls:0.48%
cases:3.93%
controls:1.84%
cases:7.75%
controls:4.31%
30
258
685
6651
31
144
685
6771
16
32
700
6883
—
26
33
686
6875
27
125
660
6684
49
268
583
5943
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
100906-7 [1761482]
2.1e+00
1.2e+00
—
—
—
2.1e+00
1.5e+00
cases:4.34%
controls:0.54%
cases:1.12%
controls:0.33%
—
—
—
—
—
—
cases:1.46%
controls:0.18%
cases:2.37%
controls:0.52%
31
37
684
6872
8
23
708
6892
—
—
—
10
12
677
6797
15
32
617
6179
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.9e-01
6.2e-01
1.5e+00
1.0e+50
2.0e+00
9.9e-01
7.2e-01
cases:8.39%
controls:6.40%
cases:6.42%
controls:3.57%
cases:2.65%
controls:0.61%
cases:0.98%
controls:0.00%
cases:3.93%
controls:0.56%
cases:7.86%
controls:3.08%
cases:12.50%
controls:6.49%
60
442
655
6467
46
247
670
6668
19
42
697
6873
7
0
709
6915
28
39
684
6869
54
210
633
6599
79
403
553
5808
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
7.8e-01
1.9e+00
—
1.0e+50
—
1.7e+00
1.4e+00
cases:3.78%
controls:1.77%
cases:2.79%
controls:0.43%
—
—
cases:1.26%
controls:0.00%
—
—
cases:2.47%
controls:0.46%
cases:5.06%
controls:1.30%
27
122
688
6787
20
30
696
6885
—
9
0
707
6915
—
17
31
670
6778
32
81
600
6130
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.7e-01
1.0e+00
1.6e+00
1.0e+50
2.0e+00
1.2e+00
8.5e-01
cases:10.49%
controls:6.21%
cases:4.75%
controls:1.76%
cases:0.84%
controls:0.17%
cases:0.70%
controls:0.00%
cases:1.40%
controls:0.19%
cases:4.51%
controls:1.35%
cases:9.02%
controls:4.06%
75
429
640
6480
34
122
682
6793
6
12
710
6903
5
0
711
6915
10
13
702
6895
31
92
656
6717
57
252
575
5959
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
1.2e+00
1.8e+00
—
—
—
1.4e+00
1.3e+00
cases:2.80%
controls:0.88%
cases:2.23%
controls:0.36%
—
—
—
—
—
—
cases:1.46%
controls:0.37%
cases:3.01%
controls:0.84%
20
61
695
6848
16
25
700
6890
—
—
—
10
25
677
6784
19
52
613
6159
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
1.4e+00
2.4e+00
—
—
—
1.9e+00
1.0e+00
cases:2.38%
controls:0.61%
cases:1.68%
controls:0.16%
—
—
—
—
—
—
cases:1.31%
controls:0.19%
cases:1.90%
controls:0.71%
17
42
698
6867
12
11
704
6904
—
—
—
9
13
678
6796
12
44
620
6167
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
1.4e+00
1.9e+00
—
—
1.0e+50
1.9e+00
1.8e+00
cases:1.26%
controls:0.32%
cases:1.40%
controls:0.20%
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.46%
controls:0.22%
cases:1.90%
controls:0.31%
9
22
706
6887
10
14
706
6901
—
—
5
0
707
6908
10
15
677
6794
12
19
620
6192
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
1.4e+00
1.9e+00
—
—
1.0e+50
1.9e+00
1.8e+00
cases:1.26%
controls:0.32%
cases:1.40%
controls:0.20%
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.46%
controls:0.22%
cases:1.90%
controls:0.31%
9
22
706
6887
10
14
706
6901
—
—
5
0
707
6908
10
15
677
6794
12
19
620
6192
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
R03DA04 [21603332]
1.4e+00
1.9e+00
—
—
—
2.0e+00
1.8e+00
cases:1.26%
controls:0.32%
cases:1.40%
controls:0.20%
—
—
—
—
—
—
cases:1.46%
controls:0.21%
cases:1.58%
controls:0.27%
9
22
706
6887
10
14
706
6901
—
—
—
10
14
677
6795
10
17
622
6194
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.6e-01
6.7e-01
1.6e+00
—
1.8e+00
6.5e-01
5.8e-01
cases:16.50%
controls:12.11%
cases:13.55%
controls:7.42%
cases:6.15%
controls:1.30%
—
—
cases:9.27%
controls:1.68%
cases:12.81%
controls:7.11%
cases:20.89%
controls:12.85%
118
837
597
6072
97
513
619
6402
44
90
672
6825
—
66
116
646
6792
88
484
599
6325
132
798
500
5413
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
15189-4 [3007778]
1.4e+00
1.9e+00
—
—
—
1.8e+00
1.9e+00
cases:1.26%
controls:0.32%
cases:1.40%
controls:0.20%
—
—
—
—
—
—
cases:1.31%
controls:0.22%
cases:1.58%
controls:0.24%
9
22
706
6887
10
14
706
6901
—
—
—
9
15
678
6794
10
15
622
6196
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
6.3e-01
1.7e+00
—
—
—
1.9e+00
2.0e+00
cases:1.54%
controls:0.83%
cases:1.26%
controls:0.23%
—
—
—
—
—
—
cases:1.31%
controls:0.19%
cases:2.53%
controls:0.35%
11
57
704
6852
9
16
707
6899
—
—
—
9
13
678
6796
16
22
616
6189
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
1.4e+00
2.1e+00
—
—
—
2.1e+00
1.1e+00
cases:1.82%
controls:0.46%
cases:1.54%
controls:0.19%
—
—
—
—
—
—
cases:1.31%
controls:0.16%
cases:1.58%
controls:0.52%
13
32
702
6877
11
13
705
6902
—
—
—
9
11
678
6798
10
32
622
6179
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
1.4e+00
2.8e+00
—
—
—
2.8e+00
—
cases:1.26%
controls:0.32%
cases:1.68%
controls:0.10%
—
—
—
—
—
—
cases:1.16%
controls:0.07%
—
—
9
22
706
6887
12
7
704
6908
—
—
—
8
5
679
6804
—
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
8.3e-02
6.3e-01
1.6e+00
—
2.0e+00
6.9e-01
6.5e-01
cases:6.57%
controls:6.08%
cases:8.66%
controls:4.82%
cases:4.89%
controls:0.98%
—
—
cases:6.60%
controls:0.98%
cases:9.32%
controls:4.89%
cases:14.56%
controls:8.15%
47
420
668
6489
62
333
654
6582
35
68
681
6847
—
47
68
665
6840
64
333
623
6476
92
506
540
5705
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
5.9e-01
1.2e+00
2.1e+00
—
1.9e+00
1.3e+00
9.4e-01
cases:3.50%
controls:1.97%
cases:2.23%
controls:0.69%
cases:0.84%
controls:0.10%
—
—
cases:0.70%
controls:0.10%
cases:2.18%
controls:0.60%
cases:4.11%
controls:1.64%
25
136
690
6773
16
48
700
6867
6
7
710
6908
—
5
7
707
6901
15
41
672
6768
26
102
606
6109
hydrocortisone; oral, parenteral
H02AB09 [21602737]
H02AB09 [21602737]
1.1e+00
1.8e+00
—
—
—
1.4e+00
1.1e+00
cases:4.76%
controls:1.58%
cases:3.35%
controls:0.55%
—
—
—
—
—
—
cases:1.89%
controls:0.48%
cases:3.80%
controls:1.26%
34
109
681
6800
24
38
692
6877
—
—
—
13
33
674
6776
24
78
608
6133
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
4.6e-01
9.2e-01
1.4e+00
—
1.5e+00
1.0e+00
5.6e-01
cases:8.67%
controls:5.66%
cases:5.87%
controls:2.42%
cases:1.68%
controls:0.42%
—
—
cases:1.40%
controls:0.30%
cases:5.39%
controls:1.97%
cases:9.34%
controls:5.57%
62
391
653
6518
42
167
674
6748
12
29
704
6886
—
10
21
702
6887
37
134
650
6675
59
346
573
5865
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
1.1e+00
2.0e+00
—
—
—
2.0e+00
1.4e+00
cases:1.12%
controls:0.38%
cases:1.54%
controls:0.20%
—
—
—
—
—
—
cases:1.16%
controls:0.16%
cases:1.58%
controls:0.39%
8
26
707
6883
11
14
705
6901
—
—
—
8
11
679
6798
10
24
622
6187
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
1.0e+00
1.9e+00
—
—
—
1.9e+00
1.5e+00
cases:0.98%
controls:0.36%
cases:0.98%
controls:0.14%
—
—
—
—
—
—
cases:1.02%
controls:0.15%
cases:1.42%
controls:0.31%
7
25
708
6884
7
10
709
6905
—
—
—
7
10
680
6799
9
19
623
6192
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
8.1e-01
1.3e+00
—
—
2.3e+00
2.1e+00
1.2e+00
cases:3.08%
controls:1.39%
cases:1.82%
controls:0.51%
—
—
—
—
cases:0.70%
controls:0.07%
cases:2.18%
controls:0.28%
cases:3.48%
controls:1.05%
22
96
693
6813
13
35
703
6880
—
—
5
5
707
6903
15
19
672
6790
22
65
610
6146
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
1.1e+00
2.0e+00
—
—
—
1.9e+00
1.4e+00
cases:1.12%
controls:0.38%
cases:1.54%
controls:0.20%
—
—
—
—
—
—
cases:1.16%
controls:0.18%
cases:1.58%
controls:0.39%
8
26
707
6883
11
14
705
6901
—
—
—
8
12
679
6797
10
24
622
6187
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.3e-01
7.2e-01
1.4e+00
—
1.6e+00
9.5e-01
6.8e-01
cases:10.07%
controls:6.80%
cases:7.68%
controls:3.90%
cases:4.75%
controls:1.21%
—
—
cases:5.34%
controls:1.13%
cases:8.30%
controls:3.39%
cases:11.08%
controls:5.96%
72
470
643
6439
55
270
661
6645
34
84
682
6831
—
38
78
674
6830
57
231
630
6578
70
370
562
5841
Dermatitis, unspecified
L30.9 [45572271]
L30.9 [45572271]
-5.3e-02
2.7e-01
2.6e+00
—
2.8e+00
8.8e-01
6.6e-01
cases:1.54%
controls:1.62%
cases:0.70%
controls:0.54%
cases:1.12%
controls:0.09%
—
—
cases:1.12%
controls:0.07%
cases:1.16%
controls:0.48%
cases:3.80%
controls:2.00%
11
112
704
6797
5
37
711
6878
8
6
708
6909
—
8
5
704
6903
8
33
679
6776
24
124
608
6087
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
1.2e+00
1.5e+00
1.5e+00
—
—
1.4e+00
1.2e+00
cases:3.08%
controls:0.94%
cases:2.51%
controls:0.59%
cases:0.70%
controls:0.16%
—
—
—
—
cases:2.33%
controls:0.56%
cases:2.85%
controls:0.90%
22
65
693
6844
18
41
698
6874
5
11
711
6904
—
—
16
38
671
6771
18
56
614
6155
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.3e-01
1.0e+00
1.4e+00
1.0e+50
2.1e+00
1.3e+00
7.7e-01
cases:6.57%
controls:3.97%
cases:4.47%
controls:1.63%
cases:1.26%
controls:0.32%
cases:0.98%
controls:0.00%
cases:1.54%
controls:0.19%
cases:5.24%
controls:1.48%
cases:7.28%
controls:3.49%
47
274
668
6635
32
113
684
6802
9
22
707
6893
7
0
709
6915
11
13
701
6895
36
101
651
6708
46
217
586
5994
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.1e+00
1.4e+00
—
1.0e+50
—
1.8e+00
9.1e-01
cases:3.36%
controls:1.16%
cases:2.09%
controls:0.52%
—
—
cases:0.84%
controls:0.00%
—
—
cases:2.77%
controls:0.47%
cases:3.16%
controls:1.30%
24
80
691
6829
15
36
701
6879
—
6
0
710
6915
—
19
32
668
6777
20
81
612
6130
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
2.0e+00
1.5e+00
—
1.0e+50
—
1.6e+00
6.3e-01
cases:2.80%
controls:0.39%
cases:1.40%
controls:0.30%
—
—
cases:0.84%
controls:0.00%
—
—
cases:1.31%
controls:0.26%
cases:1.27%
controls:0.68%
20
27
695
6882
10
21
706
6894
—
6
0
710
6915
—
9
18
678
6791
8
42
624
6169
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
6.9e-01
1.0e+00
1.3e+00
1.0e+50
2.3e+00
1.1e+00
4.3e-01
cases:6.57%
controls:3.40%
cases:5.31%
controls:1.94%
cases:1.26%
controls:0.33%
cases:0.70%
controls:0.00%
cases:1.83%
controls:0.19%
cases:4.22%
controls:1.42%
cases:6.80%
controls:4.54%
47
235
668
6674
38
134
678
6781
9
23
707
6892
5
0
711
6915
13
13
699
6895
29
97
658
6712
43
282
589
5929
Specific gravity of Urine by Test strip
5811-5 [3000330]
5811-5 [3000330]
2.0e+00
1.5e+00
—
—
—
1.6e+00
9.5e-01
cases:4.34%
controls:0.62%
cases:2.09%
controls:0.48%
—
—
—
—
—
—
cases:2.04%
controls:0.41%
cases:2.53%
controls:1.00%
31
43
684
6866
15
33
701
6882
—
—
—
14
28
673
6781
16
62
616
6149
General Practice
1 [38004446]
1 [38004446]
1.1e-01
4.3e-01
2.0e+00
—
2.4e+00
6.8e-01
4.0e-01
cases:9.93%
controls:8.99%
cases:5.45%
controls:3.60%
cases:3.63%
controls:0.51%
—
—
cases:5.62%
controls:0.55%
cases:7.86%
controls:4.13%
cases:14.08%
controls:9.92%
71
621
644
6288
39
249
677
6666
26
35
690
6880
—
40
38
672
6870
54
281
633
6528
89
616
543
5595
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
2.4e-01
5.9e-01
1.5e+00
—
2.0e+00
8.6e-01
7.1e-01
cases:4.90%
controls:3.91%
cases:3.63%
controls:2.05%
cases:1.68%
controls:0.39%
—
—
cases:2.53%
controls:0.35%
cases:4.51%
controls:1.97%
cases:7.91%
controls:4.06%
35
270
680
6639
26
142
690
6773
12
27
704
6888
—
18
24
694
6884
31
134
656
6675
50
252
582
5959
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
6.8e-01
1.1e+00
7.5e-01
—
1.8e+00
7.6e-01
6.5e-01
cases:7.97%
controls:4.21%
cases:7.68%
controls:2.65%
cases:0.98%
controls:0.46%
—
—
cases:2.39%
controls:0.39%
cases:6.11%
controls:2.97%
cases:12.82%
controls:7.10%
57
291
658
6618
55
183
661
6732
7
32
709
6883
—
17
27
695
6881
42
202
645
6607
81
441
551
5770
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.1e-01
2.9e-01
8.3e-01
2.8e+00
1.1e+00
3.7e-01
4.5e-01
cases:84.20%
controls:81.16%
cases:74.44%
controls:68.53%
cases:52.37%
controls:32.39%
cases:19.55%
controls:1.52%
cases:58.71%
controls:32.66%
cases:75.98%
controls:68.66%
cases:92.41%
controls:88.62%
602
5607
113
1302
533
4739
183
2176
375
2240
341
4675
140
105
576
6810
418
2256
294
4652
522
4675
165
2134
584
5504
48
707
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
3.2e-01
1.0e+00
1.4e+00
—
2.2e+00
1.1e+00
7.7e-01
cases:5.17%
controls:3.82%
cases:5.31%
controls:1.95%
cases:1.26%
controls:0.30%
—
—
cases:1.97%
controls:0.23%
cases:5.09%
controls:1.82%
cases:10.28%
controls:5.04%
37
264
678
6645
38
135
678
6780
9
21
707
6894
—
14
16
698
6892
35
124
652
6685
65
313
567
5898
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
4.2e-01
1.3e+00
2.9e+00
1.0e+50
—
1.2e+00
8.1e-01
cases:1.40%
controls:0.93%
cases:1.68%
controls:0.45%
cases:1.26%
controls:0.07%
cases:0.70%
controls:0.00%
—
—
cases:1.60%
controls:0.47%
cases:4.11%
controls:1.87%
10
64
705
6845
12
31
704
6884
9
5
707
6910
5
0
711
6915
—
11
32
676
6777
26
116
606
6095
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
8.5e-01
1.8e+00
—
—
—
1.8e+00
1.4e+00
cases:2.10%
controls:0.91%
cases:1.26%
controls:0.22%
—
—
—
—
—
—
cases:1.46%
controls:0.23%
cases:3.01%
controls:0.77%
15
63
700
6846
9
15
707
6900
—
—
—
10
16
677
6793
19
48
613
6163
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
2.2e+00
2.7e+00
—
—
—
—
1.3e+00
cases:1.82%
controls:0.20%
cases:1.12%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.26%
13
14
702
6895
8
5
708
6910
—
—
—
—
6
16
626
6195
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
7.6e-01
1.8e+00
—
—
—
1.7e+00
1.4e+00
cases:1.54%
controls:0.72%
cases:2.65%
controls:0.43%
—
—
—
—
—
—
cases:2.33%
controls:0.44%
cases:4.91%
controls:1.26%
11
50
704
6859
19
30
697
6885
—
—
—
16
30
671
6779
31
78
601
6133
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
1.4e+00
1.6e+00
1.0e+50
1.0e+50
—
1.9e+00
1.3e+00
cases:1.12%
controls:0.28%
cases:1.12%
controls:0.22%
cases:0.84%
controls:0.00%
cases:1.26%
controls:0.00%
—
—
cases:1.31%
controls:0.19%
cases:2.85%
controls:0.77%
8
19
707
6890
8
15
708
6900
6
0
710
6915
9
0
707
6915
—
9
13
678
6796
18
48
614
6163
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
2.1e+00
2.7e+00
—
—
—
—
1.3e+00
cases:1.82%
controls:0.22%
cases:1.12%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.79%
controls:0.21%
13
15
702
6894
8
5
708
6910
—
—
—
—
5
13
627
6198
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
1.5e+00
1.6e+00
1.0e+50
1.0e+50
—
1.9e+00
1.4e+00
cases:1.12%
controls:0.25%
cases:1.12%
controls:0.22%
cases:0.84%
controls:0.00%
cases:1.26%
controls:0.00%
—
—
cases:1.31%
controls:0.21%
cases:3.16%
controls:0.82%
8
17
707
6892
8
15
708
6900
6
0
710
6915
9
0
707
6915
—
9
14
678
6795
20
51
612
6160
General evaluation of the need for rehabilitation
R1100 [2001310172]
R1100 [2001310172]
2.2e+00
—
—
—
—
2.6e+00
—
cases:1.82%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.07%
—
—
13
14
702
6895
—
—
—
—
7
5
680
6804
—
hydrocortisone aceponate
D07AC16 [21602135]
D07AC16 [21602135]
4.5e-01
5.1e-01
1.8e+00
—
1.5e+00
8.4e-01
6.2e-01
cases:9.65%
controls:6.35%
cases:3.49%
controls:2.13%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.20%
cases:11.39%
controls:6.46%
69
439
646
6470
25
147
691
6768
9
14
707
6901
—
9
19
703
6889
34
150
653
6659
72
401
560
5810
hydrocortisone
D07AA02 [21602102]
D07AA02 [21602102]
4.5e-01
5.1e-01
1.8e+00
—
1.5e+00
8.4e-01
6.2e-01
cases:9.65%
controls:6.35%
cases:3.49%
controls:2.13%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.20%
cases:11.39%
controls:6.46%
69
439
646
6470
25
147
691
6768
9
14
707
6901
—
9
19
703
6889
34
150
653
6659
72
401
560
5810
hydrocortisone butyrate
D07AB02 [21602106]
D07AB02 [21602106]
4.5e-01
5.1e-01
1.8e+00
—
1.5e+00
8.4e-01
6.2e-01
cases:9.65%
controls:6.35%
cases:3.49%
controls:2.13%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.20%
cases:11.39%
controls:6.46%
69
439
646
6470
25
147
691
6768
9
14
707
6901
—
9
19
703
6889
34
150
653
6659
72
401
560
5810
hydrocortisone buteprate
D07AB11 [21602115]
D07AB11 [21602115]
4.5e-01
5.1e-01
1.8e+00
—
1.5e+00
8.4e-01
6.2e-01
cases:9.65%
controls:6.35%
cases:3.49%
controls:2.13%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.20%
cases:11.39%
controls:6.46%
69
439
646
6470
25
147
691
6768
9
14
707
6901
—
9
19
703
6889
34
150
653
6659
72
401
560
5810
hydrocortisone
A07EA02 [21600654]
A07EA02 [21600654]
4.4e-01
5.0e-01
1.8e+00
—
1.5e+00
8.3e-01
6.1e-01
cases:9.65%
controls:6.41%
cases:3.49%
controls:2.15%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.22%
cases:11.39%
controls:6.52%
69
443
646
6466
25
149
691
6766
9
14
707
6901
—
9
19
703
6889
34
151
653
6658
72
405
560
5806
hydrocortisone
C05AA01 [21601608]
C05AA01 [21601608]
4.4e-01
5.0e-01
1.8e+00
—
1.5e+00
8.3e-01
6.1e-01
cases:9.65%
controls:6.41%
cases:3.49%
controls:2.15%
cases:1.26%
controls:0.20%
—
—
cases:1.26%
controls:0.28%
cases:4.95%
controls:2.22%
cases:11.39%
controls:6.52%
69
443
646
6466
25
149
691
6766
9
14
707
6901
—
9
19
703
6889
34
151
653
6658
72
405
560
5806
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
2.2e-01
8.7e-01
1.7e+00
1.0e+50
1.6e+00
5.2e-01
5.9e-01
cases:4.48%
controls:3.63%
cases:5.03%
controls:2.17%
cases:1.40%
controls:0.26%
cases:1.40%
controls:0.00%
cases:1.26%
controls:0.25%
cases:3.20%
controls:1.92%
cases:8.07%
controls:4.65%
32
251
683
6658
36
150
680
6765
10
18
706
6897
10
0
706
6915
9
17
703
6891
22
131
665
6678
51
289
581
5922
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
3.2e-01
6.2e-01
1.4e+00
—
1.5e+00
6.1e-01
5.3e-01
cases:14.55%
controls:11.04%
cases:10.34%
controls:5.83%
cases:3.07%
controls:0.75%
—
—
cases:3.51%
controls:0.77%
cases:9.46%
controls:5.36%
cases:18.35%
controls:11.64%
104
763
611
6146
74
403
642
6512
22
52
694
6863
—
25
53
687
6855
65
365
622
6444
116
723
516
5488
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
8.7e-01
1.7e+00
—
—
—
1.7e+00
1.4e+00
cases:1.40%
controls:0.59%
cases:2.09%
controls:0.40%
—
—
—
—
—
—
cases:2.18%
controls:0.40%
cases:4.43%
controls:1.18%
10
41
705
6868
15
28
701
6887
—
—
—
15
27
672
6782
28
73
604
6138
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.9e-01
1.1e+00
1.3e+00
—
—
1.7e+00
1.3e+00
cases:8.67%
controls:4.98%
cases:3.63%
controls:1.21%
cases:0.70%
controls:0.19%
—
—
—
—
cases:4.51%
controls:0.88%
cases:8.86%
controls:2.53%
62
344
653
6565
26
84
690
6831
5
13
711
6902
—
—
31
60
656
6749
56
157
576
6054
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
1.1e+00
2.3e+00
2.3e+00
—
—
8.7e-01
1.3e+00
cases:2.10%
controls:0.71%
cases:2.93%
controls:0.29%
cases:0.70%
controls:0.07%
—
—
—
—
cases:0.87%
controls:0.37%
cases:4.11%
controls:1.21%
15
49
700
6860
21
20
695
6895
5
5
711
6910
—
—
6
25
681
6784
26
75
606
6136
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
1.0e+00
1.5e+00
7.9e-01
—
1.1e+00
1.2e+00
8.8e-01
cases:3.78%
controls:1.38%
cases:2.93%
controls:0.68%
cases:0.70%
controls:0.32%
—
—
cases:0.84%
controls:0.29%
cases:2.18%
controls:0.65%
cases:4.11%
controls:1.75%
27
95
688
6814
21
47
695
6868
5
22
711
6893
—
6
20
706
6888
15
44
672
6765
26
109
606
6102
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
1.6e+00
1.5e+00
—
—
—
1.3e+00
1.5e+00
cases:1.96%
controls:0.39%
cases:1.40%
controls:0.32%
—
—
—
—
—
—
cases:0.87%
controls:0.23%
cases:2.37%
controls:0.55%
14
27
701
6882
10
22
706
6893
—
—
—
6
16
681
6793
15
34
617
6177
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.4e-01
8.1e-01
1.6e+00
—
1.7e+00
4.9e-01
5.4e-01
cases:5.73%
controls:5.01%
cases:6.01%
controls:2.76%
cases:1.82%
controls:0.39%
—
—
cases:1.83%
controls:0.35%
cases:3.78%
controls:2.35%
cases:9.02%
controls:5.47%
41
346
674
6563
43
191
673
6724
13
27
703
6888
—
13
24
699
6884
26
160
661
6649
57
340
575
5871
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
WD125 [2001310680]
1.4e+00
2.3e+00
—
—
—
—
2.3e+00
cases:0.84%
controls:0.22%
cases:1.12%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.11%
6
15
709
6894
8
8
708
6907
—
—
—
—
7
7
625
6204
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
8.2e-01
1.7e+00
—
—
—
1.5e+00
1.4e+00
cases:1.54%
controls:0.68%
cases:2.23%
controls:0.42%
—
—
—
—
—
—
cases:1.89%
controls:0.43%
cases:4.59%
controls:1.21%
11
47
704
6862
16
29
700
6886
—
—
—
13
29
674
6780
29
75
603
6136
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
1.1e+00
1.8e+00
—
—
—
1.5e+00
1.5e+00
cases:2.10%
controls:0.68%
cases:1.82%
controls:0.30%
—
—
—
—
—
—
cases:1.31%
controls:0.31%
cases:2.85%
controls:0.64%
15
47
700
6862
13
21
703
6894
—
—
—
9
21
678
6788
18
40
614
6171
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.0e-01
4.7e-01
1.0e+00
—
1.9e+00
5.7e-01
5.2e-01
cases:13.71%
controls:11.51%
cases:9.22%
controls:5.94%
cases:2.37%
controls:0.87%
—
—
cases:4.78%
controls:0.77%
cases:9.17%
controls:5.42%
cases:19.15%
controls:12.38%
98
795
617
6114
66
411
650
6504
17
60
699
6855
—
34
53
678
6855
63
369
624
6440
121
769
511
5442
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.8e-01
5.9e-01
1.3e+00
—
1.7e+00
7.7e-01
3.6e-01
cases:12.03%
controls:8.57%
cases:6.84%
controls:3.90%
cases:1.82%
controls:0.49%
—
—
cases:2.67%
controls:0.49%
cases:7.71%
controls:3.72%
cases:14.24%
controls:10.34%
86
592
629
6317
49
270
667
6645
13
34
703
6881
—
19
34
693
6874
53
253
634
6556
90
642
542
5569
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
—
2.6e+00
—
—
1.0e+50
—
1.8e+00
—
—
cases:0.98%
controls:0.07%
—
—
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.58%
controls:0.27%
—
7
5
709
6910
—
—
7
0
705
6908
—
10
17
622
6194
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
DM1AA [2001301740]
2.3e+00
—
—
—
—
—
2.1e+00
cases:0.98%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.18%
7
7
708
6902
—
—
—
—
—
9
11
623
6200
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.8e-01
1.8e-01
6.6e-01
3.2e+00
4.4e-01
6.2e-02
1.2e-01
cases:46.99%
controls:42.55%
cases:40.64%
controls:36.34%
cases:25.70%
controls:15.14%
cases:20.67%
controls:1.01%
cases:21.63%
controls:15.14%
cases:40.17%
controls:38.68%
cases:53.64%
controls:50.67%
336
2940
379
3969
291
2513
425
4402
184
1047
532
5868
148
70
568
6845
154
1046
558
5862
276
2634
411
4175
339
3147
293
3064
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
7.2e-01
1.1e+00
—
—
—
1.4e+00
1.1e+00
cases:5.31%
controls:2.65%
cases:2.37%
controls:0.77%
—
—
—
—
—
—
cases:2.47%
controls:0.63%
cases:6.65%
controls:2.38%
38
183
677
6726
17
53
699
6862
—
—
—
17
43
670
6766
42
148
590
6063
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
—
2.6e+00
—
—
1.0e+50
—
1.7e+00
—
—
cases:1.40%
controls:0.10%
—
—
—
—
cases:1.40%
controls:0.00%
—
—
cases:2.22%
controls:0.42%
—
10
7
706
6908
—
—
10
0
702
6908
—
14
26
618
6185
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
117 [2001600117]
1.6e+00
2.7e+00
—
—
—
—
1.6e+00
cases:3.64%
controls:0.72%
cases:2.23%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.19%
26
50
689
6859
16
11
700
6904
—
—
—
—
6
12
626
6199
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
1.0e+00
2.0e+00
—
—
—
1.2e+00
1.3e+00
cases:2.80%
controls:1.01%
cases:2.37%
controls:0.33%
—
—
—
—
—
—
cases:1.46%
controls:0.46%
cases:4.11%
controls:1.18%
20
70
695
6839
17
23
699
6892
—
—
—
10
31
677
6778
26
73
606
6138
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
1.5e+00
2.3e+00
—
—
—
—
2.0e+00
cases:1.12%
controls:0.26%
cases:0.98%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.26%
8
18
707
6891
7
7
709
6908
—
—
—
—
12
16
620
6195
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.7e-01
1.2e+00
1.9e+00
—
—
1.3e+00
9.3e-01
cases:4.20%
controls:1.81%
cases:2.37%
controls:0.75%
cases:0.70%
controls:0.10%
—
—
—
—
cases:2.18%
controls:0.60%
cases:4.91%
controls:2.00%
30
125
685
6784
17
52
699
6863
5
7
711
6908
—
—
15
41
672
6768
31
124
601
6087
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
C91.1 [45600564]
1.8e+00
2.4e+00
—
—
—
—
—
cases:0.98%
controls:0.16%
cases:1.12%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
7
11
708
6898
8
7
708
6908
—
—
—
—
—
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
1.5e+00
2.3e+00
—
—
—
—
2.0e+00
cases:1.12%
controls:0.25%
cases:0.98%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.27%
8
17
707
6892
7
7
709
6908
—
—
—
—
12
17
620
6194
tacrolimus; oral, parenteral
L04AD02 [21603925]
L04AD02 [21603925]
—
2.0e+00
—
—
—
2.0e+00
2.2e+00
—
—
cases:0.84%
controls:0.12%
—
—
—
—
—
—
cases:0.87%
controls:0.12%
cases:1.42%
controls:0.16%
—
6
8
710
6907
—
—
—
6
8
681
6801
9
10
623
6201
hydrocortisone
S02BA01 [21605166]
S02BA01 [21605166]
4.8e-01
5.0e-01
2.1e+00
—
1.1e+00
9.1e-01
7.2e-01
cases:8.81%
controls:5.62%
cases:3.07%
controls:1.89%
cases:1.26%
controls:0.16%
—
—
cases:0.70%
controls:0.25%
cases:4.80%
controls:1.98%
cases:10.76%
controls:5.52%
63
388
652
6521
22
131
694
6784
9
11
707
6904
—
5
17
707
6891
33
135
654
6674
68
343
564
5868
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
6.0e-01
1.4e+00
—
—
—
1.4e+00
1.3e+00
cases:1.26%
controls:0.69%
cases:1.68%
controls:0.40%
—
—
—
—
—
—
cases:1.89%
controls:0.46%
cases:4.11%
controls:1.14%
9
48
706
6861
12
28
704
6887
—
—
—
13
31
674
6778
26
71
606
6140
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
7.1e-01
1.2e+00
—
1.0e+50
2.3e+00
5.1e-01
6.6e-01
cases:6.15%
controls:3.11%
cases:2.79%
controls:0.90%
—
—
cases:0.70%
controls:0.00%
cases:0.98%
controls:0.10%
cases:1.31%
controls:0.79%
cases:4.91%
controls:2.61%
44
215
671
6694
20
62
696
6853
—
5
0
711
6915
7
7
705
6901
9
54
678
6755
31
162
601
6049
Otolaryngology
4 [38004449]
4 [38004449]
3.5e-01
5.0e-01
1.3e+00
—
1.7e+00
6.3e-01
5.0e-01
cases:14.83%
controls:10.93%
cases:6.42%
controls:4.01%
cases:2.65%
controls:0.71%
—
—
cases:2.95%
controls:0.56%
cases:6.99%
controls:3.86%
cases:15.03%
controls:9.66%
106
755
609
6154
46
277
670
6638
19
49
697
6866
—
21
39
691
6869
48
263
639
6546
95
600
537
5611
rivaroxaban; oral
B01AF01 [43534761]
B01AF01 [43534761]
7.2e-01
3.7e-01
—
1.0e+50
1.7e+00
1.3e+00
1.2e+00
cases:2.80%
controls:1.38%
cases:1.40%
controls:0.97%
—
—
cases:1.68%
controls:0.00%
cases:2.53%
controls:0.48%
cases:3.35%
controls:0.95%
cases:3.32%
controls:1.05%
20
95
695
6814
10
67
706
6848
—
12
0
704
6915
18
33
694
6875
23
65
664
6744
21
65
611
6146
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
—
2.5e+00
—
—
1.0e+50
—
1.6e+00
—
—
cases:1.26%
controls:0.10%
—
—
—
—
cases:1.40%
controls:0.00%
—
—
cases:2.06%
controls:0.42%
—
9
7
707
6908
—
—
10
0
702
6908
—
13
26
619
6185
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
8.7e-01
5.9e-01
1.9e+00
—
1.2e+00
8.2e-01
5.6e-01
cases:6.01%
controls:2.62%
cases:3.35%
controls:1.89%
cases:1.40%
controls:0.22%
—
—
cases:0.70%
controls:0.22%
cases:3.64%
controls:1.63%
cases:8.23%
controls:4.86%
43
181
672
6728
24
131
692
6784
10
15
706
6900
—
5
15
707
6893
25
111
662
6698
52
302
580
5909
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
1.7e+00
2.4e+00
—
—
—
—
9.1e-01
cases:1.96%
controls:0.36%
cases:1.12%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.58%
14
25
701
6884
8
7
708
6908
—
—
—
—
9
36
623
6175
High dependency care
WX882 [2001310847]
WX882 [2001310847]
1.2e+00
2.1e+00
—
—
—
—
1.9e+00
cases:0.98%
controls:0.30%
cases:0.84%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.21%
7
21
708
6888
6
7
710
6908
—
—
—
—
9
13
623
6198
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
1.1e+00
2.0e+00
—
—
—
2.0e+00
1.3e+00
cases:1.12%
controls:0.38%
cases:1.54%
controls:0.20%
—
—
—
—
—
—
cases:1.16%
controls:0.16%
cases:1.42%
controls:0.39%
8
26
707
6883
11
14
705
6901
—
—
—
8
11
679
6798
9
24
623
6187
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.8e-01
8.4e-01
1.5e+00
—
1.6e+00
5.6e-01
4.7e-01
cases:5.45%
controls:4.20%
cases:5.45%
controls:2.43%
cases:1.68%
controls:0.36%
—
—
cases:1.54%
controls:0.30%
cases:3.78%
controls:2.20%
cases:8.54%
controls:5.51%
39
290
676
6619
39
168
677
6747
12
25
704
6890
—
11
21
701
6887
26
150
661
6659
54
342
578
5869
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
6.8e-01
9.6e-01
—
—
-1.0e+50
1.3e+00
1.0e+00
cases:7.27%
controls:3.82%
cases:3.07%
controls:1.20%
—
—
—
—
cases:0.00%
controls:0.13%
cases:3.35%
controls:0.91%
cases:6.80%
controls:2.50%
52
264
663
6645
22
83
694
6832
—
—
0
9
712
6899
23
62
664
6747
43
155
589
6056
Other chronic renal failure
N18.8 [45534123]
N18.8 [45534123]
2.0e+00
2.1e+00
—
—
—
—
1.6e+00
cases:1.12%
controls:0.16%
cases:1.12%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.23%
8
11
707
6898
8
10
708
6905
—
—
—
—
7
14
625
6197
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
1.8e+00
—
—
—
—
—
2.2e+00
cases:1.12%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.19%
8
13
707
6896
—
—
—
—
—
11
12
621
6199
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
29257-3 [3002482]
—
2.5e+00
—
—
1.0e+50
—
1.5e+00
—
—
cases:0.84%
controls:0.07%
—
—
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.74%
controls:0.39%
—
6
5
710
6910
—
—
7
0
705
6908
—
11
24
621
6187
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
1.8e+00
2.2e+00
—
—
—
1.8e+00
1.2e+00
cases:2.52%
controls:0.42%
cases:1.96%
controls:0.23%
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:1.27%
controls:0.40%
18
29
697
6880
14
16
702
6899
—
—
—
5
8
682
6801
8
25
624
6186
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
6.6e-01
1.3e+00
—
—
—
1.6e+00
2.4e+00
cases:1.26%
controls:0.65%
cases:0.70%
controls:0.19%
—
—
—
—
—
—
cases:1.31%
controls:0.28%
cases:2.22%
controls:0.21%
9
45
706
6864
5
13
711
6902
—
—
—
9
19
678
6790
14
13
618
6198
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
1.1e+00
2.0e+00
—
—
—
1.9e+00
1.1e+00
cases:1.12%
controls:0.36%
cases:1.26%
controls:0.17%
—
—
—
—
—
—
cases:1.16%
controls:0.18%
cases:1.11%
controls:0.37%
8
25
707
6884
9
12
707
6903
—
—
—
8
12
679
6797
7
23
625
6188
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
5.9e-01
1.2e+00
—
—
2.1e+00
6.3e-01
6.1e-01
cases:4.76%
controls:2.69%
cases:4.19%
controls:1.34%
—
—
—
—
cases:1.12%
controls:0.14%
cases:2.77%
controls:1.50%
cases:6.49%
controls:3.62%
34
186
681
6723
30
93
686
6822
—
—
8
10
704
6898
19
102
668
6707
41
225
591
5986
antibiotics in combination with corticosteroids
D01AA20 [21601918]
D01AA20 [21601918]
9.8e-01
5.8e-01
—
—
—
1.7e+00
1.2e+00
cases:4.62%
controls:1.78%
cases:0.70%
controls:0.39%
—
—
—
—
—
—
cases:2.04%
controls:0.40%
cases:4.11%
controls:1.30%
33
123
682
6786
5
27
711
6888
—
—
—
14
27
673
6782
26
81
606
6130
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
6.7e-01
7.3e-01
—
1.0e+50
2.6e+00
1.2e+00
6.0e-01
cases:3.92%
controls:2.04%
cases:1.96%
controls:0.95%
—
—
cases:0.70%
controls:0.00%
cases:1.12%
controls:0.09%
cases:2.62%
controls:0.79%
cases:4.27%
controls:2.38%
28
141
687
6768
14
66
702
6849
—
5
0
711
6915
8
6
704
6902
18
54
669
6755
27
148
605
6063
FEV1
20150-9 [3024653]
20150-9 [3024653]
8.2e-01
1.9e+00
—
—
—
7.7e-01
1.9e+00
cases:2.38%
controls:1.06%
cases:1.68%
controls:0.26%
—
—
—
—
—
—
cases:0.73%
controls:0.34%
cases:4.27%
controls:0.69%
17
73
698
6836
12
18
704
6897
—
—
—
5
23
682
6786
27
43
605
6168
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
8.2e-01
1.9e+00
—
—
—
7.7e-01
1.9e+00
cases:2.38%
controls:1.06%
cases:1.68%
controls:0.26%
—
—
—
—
—
—
cases:0.73%
controls:0.34%
cases:4.27%
controls:0.69%
17
73
698
6836
12
18
704
6897
—
—
—
5
23
682
6786
27
43
605
6168
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
8.2e-01
1.9e+00
—
—
—
7.7e-01
1.9e+00
cases:2.38%
controls:1.06%
cases:1.68%
controls:0.26%
—
—
—
—
—
—
cases:0.73%
controls:0.34%
cases:4.27%
controls:0.69%
17
73
698
6836
12
18
704
6897
—
—
—
5
23
682
6786
27
43
605
6168
combinations of corticosteroids
D07AB30 [21602118]
D07AB30 [21602118]
4.0e-01
4.9e-01
1.5e+00
—
1.6e+00
4.8e-01
5.8e-01
cases:12.03%
controls:8.39%
cases:4.33%
controls:2.70%
cases:1.54%
controls:0.33%
—
—
cases:1.26%
controls:0.26%
cases:4.51%
controls:2.83%
cases:14.08%
controls:8.37%
86
580
629
6329
31
187
685
6728
11
23
705
6892
—
9
18
703
6890
31
193
656
6616
89
520
543
5691
combinations of corticosteroids
D07XB30 [21602188]
D07XB30 [21602188]
4.0e-01
4.9e-01
1.5e+00
—
1.6e+00
4.8e-01
5.8e-01
cases:12.03%
controls:8.39%
cases:4.33%
controls:2.70%
cases:1.54%
controls:0.33%
—
—
cases:1.26%
controls:0.26%
cases:4.51%
controls:2.83%
cases:14.08%
controls:8.37%
86
580
629
6329
31
187
685
6728
11
23
705
6892
—
9
18
703
6890
31
193
656
6616
89
520
543
5691
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
4.3e-01
4.5e-01
1.6e+00
—
1.5e+00
6.6e-01
2.8e-01
cases:8.67%
controls:5.83%
cases:4.89%
controls:3.18%
cases:1.96%
controls:0.42%
—
—
cases:1.54%
controls:0.36%
cases:5.39%
controls:2.85%
cases:9.02%
controls:6.97%
62
403
653
6506
35
220
681
6695
14
29
702
6886
—
11
25
701
6883
37
194
650
6615
57
433
575
5778
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
7.6e-01
1.2e+00
1.9e+00
—
—
1.4e+00
9.9e-01
cases:2.80%
controls:1.33%
cases:1.68%
controls:0.49%
cases:0.70%
controls:0.10%
—
—
—
—
cases:1.89%
controls:0.46%
cases:3.96%
controls:1.51%
20
92
695
6817
12
34
704
6881
5
7
711
6908
—
—
13
31
674
6778
25
94
607
6117
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
3.0e-01
5.9e-01
1.2e+00
—
2.1e+00
8.6e-01
6.7e-01
cases:4.76%
controls:3.58%
cases:2.65%
controls:1.49%
cases:1.12%
controls:0.33%
—
—
cases:1.54%
controls:0.19%
cases:3.78%
controls:1.63%
cases:7.91%
controls:4.20%
34
247
681
6662
19
103
697
6812
8
23
708
6892
—
11
13
701
6895
26
111
661
6698
50
261
582
5950
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
6.0e-01
9.4e-01
—
—
—
1.2e+00
9.2e-01
cases:6.01%
controls:3.39%
cases:2.37%
controls:0.94%
—
—
—
—
—
—
cases:1.89%
controls:0.59%
cases:5.38%
controls:2.22%
43
234
672
6675
17
65
699
6850
—
—
—
13
40
674
6769
34
138
598
6073
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
8.6e-01
1.8e+00
—
—
—
9.6e-01
1.9e+00
cases:1.96%
controls:0.84%
cases:1.12%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.28%
cases:3.48%
controls:0.56%
14
58
701
6851
8
13
708
6902
—
—
—
5
19
682
6790
22
35
610
6176
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
8.6e-01
1.8e+00
—
—
—
9.6e-01
1.9e+00
cases:1.96%
controls:0.84%
cases:1.12%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.28%
cases:3.48%
controls:0.56%
14
58
701
6851
8
13
708
6902
—
—
—
5
19
682
6790
22
35
610
6176
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
8.6e-01
1.8e+00
—
—
—
9.6e-01
1.9e+00
cases:1.96%
controls:0.84%
cases:1.12%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.28%
cases:3.48%
controls:0.56%
14
58
701
6851
8
13
708
6902
—
—
—
5
19
682
6790
22
35
610
6176
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
8.6e-01
1.8e+00
—
—
—
9.6e-01
1.9e+00
cases:1.96%
controls:0.84%
cases:1.12%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.28%
cases:3.48%
controls:0.56%
14
58
701
6851
8
13
708
6902
—
—
—
5
19
682
6790
22
35
610
6176
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
8.6e-01
1.8e+00
—
—
—
9.6e-01
1.9e+00
cases:1.96%
controls:0.84%
cases:1.12%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.28%
cases:3.48%
controls:0.56%
14
58
701
6851
8
13
708
6902
—
—
—
5
19
682
6790
22
35
610
6176
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
3.3e-01
7.8e-01
1.4e+00
—
1.4e+00
4.6e-01
4.1e-01
cases:6.43%
controls:4.72%
cases:6.01%
controls:2.85%
cases:1.68%
controls:0.40%
—
—
cases:1.54%
controls:0.38%
cases:4.08%
controls:2.61%
cases:9.18%
controls:6.30%
46
326
669
6583
43
197
673
6718
12
28
704
6887
—
11
26
701
6882
28
178
659
6631
58
391
574
5820
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
1.0e+00
1.9e+00
—
—
—
1.7e+00
1.7e+00
cases:0.98%
controls:0.35%
cases:1.26%
controls:0.19%
—
—
—
—
—
—
cases:0.87%
controls:0.16%
cases:1.42%
controls:0.26%
7
24
708
6885
9
13
707
6902
—
—
—
6
11
681
6798
9
16
623
6195
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
6.9e-01
1.2e+00
—
—
—
1.5e+00
9.3e-01
cases:2.38%
controls:1.20%
cases:1.96%
controls:0.62%
—
—
—
—
—
—
cases:2.04%
controls:0.46%
cases:3.32%
controls:1.34%
17
83
698
6826
14
43
702
6872
—
—
—
14
31
673
6778
21
83
611
6128
Pediatric Hematology-Oncology
OMOP4822028 [45756811]
OMOP4822028 [45756811]
6.5e-01
1.2e+00
1.1e+00
—
1.0e+00
1.1e+00
1.2e+00
cases:1.54%
controls:0.81%
cases:2.23%
controls:0.65%
cases:1.26%
controls:0.40%
—
—
cases:0.98%
controls:0.35%
cases:1.89%
controls:0.62%
cases:2.37%
controls:0.72%
11
56
704
6853
16
45
700
6870
9
28
707
6887
—
7
24
705
6884
13
42
674
6767
15
45
617
6166
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
9.2e-01
1.7e+00
—
—
—
9.6e-01
9.5e-01
cases:3.36%
controls:1.36%
cases:2.79%
controls:0.52%
—
—
—
—
—
—
cases:1.60%
controls:0.62%
cases:5.22%
controls:2.08%
24
94
691
6815
20
36
696
6879
—
—
—
11
42
676
6767
33
129
599
6082
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
2.0e+00
1.6e+00
—
1.0e+50
—
1.5e+00
5.2e-01
cases:2.80%
controls:0.39%
cases:1.40%
controls:0.29%
—
—
cases:0.84%
controls:0.00%
—
—
cases:1.16%
controls:0.25%
cases:1.11%
controls:0.66%
20
27
695
6882
10
20
706
6895
—
6
0
710
6915
—
8
17
679
6792
7
41
625
6170
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
2.9e-01
6.8e-01
9.2e-01
—
9.8e-01
5.5e-01
4.4e-01
cases:12.73%
controls:9.86%
cases:10.34%
controls:5.51%
cases:3.21%
controls:1.30%
—
—
cases:3.65%
controls:1.40%
cases:9.17%
controls:5.49%
cases:15.66%
controls:10.67%
91
681
624
6228
74
381
642
6534
23
90
693
6825
—
26
97
686
6811
63
374
624
6435
99
663
533
5548
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
NK6MA [2001308495]
1.4e+00
2.1e+00
—
—
—
1.7e+00
1.4e+00
cases:0.98%
controls:0.25%
cases:0.84%
controls:0.10%
—
—
—
—
—
—
cases:0.73%
controls:0.13%
cases:1.74%
controls:0.42%
7
17
708
6892
6
7
710
6908
—
—
—
5
9
682
6800
11
26
621
6185
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
8.1e-01
1.4e+00
—
1.0e+50
—
1.7e+00
1.8e+00
cases:1.68%
controls:0.75%
cases:1.12%
controls:0.27%
—
—
cases:0.70%
controls:0.00%
—
—
cases:1.75%
controls:0.31%
cases:4.27%
controls:0.74%
12
52
703
6857
8
19
708
6896
—
5
0
711
6915
—
12
21
675
6788
27
46
605
6165
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
8.6e-01
1.0e+00
—
1.0e+50
2.0e+00
1.5e+00
1.2e+00
cases:3.08%
controls:1.33%
cases:1.82%
controls:0.65%
—
—
cases:1.40%
controls:0.00%
cases:0.84%
controls:0.12%
cases:2.62%
controls:0.62%
cases:5.06%
controls:1.63%
22
92
693
6817
13
45
703
6870
—
10
0
706
6915
6
8
706
6900
18
42
669
6767
32
101
600
6110
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
5.4e-01
6.2e-01
2.5e+00
—
—
8.8e-01
1.0e+00
cases:2.80%
controls:1.65%
cases:1.26%
controls:0.68%
cases:0.84%
controls:0.07%
—
—
—
—
cases:1.16%
controls:0.48%
cases:3.96%
controls:1.45%
20
114
695
6795
9
47
707
6868
6
5
710
6910
—
—
8
33
679
6776
25
90
607
6121
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
9.2e-01
1.2e+00
2.1e+00
—
—
1.1e+00
1.3e+00
cases:4.06%
controls:1.66%
cases:1.82%
controls:0.55%
cases:0.70%
controls:0.09%
—
—
—
—
cases:1.31%
controls:0.44%
cases:3.96%
controls:1.08%
29
115
686
6794
13
38
703
6877
5
6
711
6909
—
—
9
30
678
6779
25
67
607
6144
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
2.0e+00
1.8e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:0.36%
cases:0.70%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.45%
18
25
697
6884
5
8
711
6907
—
—
—
—
12
28
620
6183
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
1.0e+00
1.2e+00
2.1e+00
—
—
1.1e+00
1.1e+00
cases:2.38%
controls:0.87%
cases:2.09%
controls:0.62%
cases:0.70%
controls:0.09%
—
—
—
—
cases:1.60%
controls:0.51%
cases:4.11%
controls:1.37%
17
60
698
6849
15
43
701
6872
5
6
711
6909
—
—
11
35
676
6774
26
85
606
6126
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
1.4e+00
2.0e+00
—
—
—
—
1.5e+00
cases:1.68%
controls:0.42%
cases:1.12%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.29%
12
29
703
6880
8
11
708
6904
—
—
—
—
8
18
624
6193
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
6.4e-01
9.1e-01
3.5e-01
—
6.1e-01
8.7e-01
9.2e-01
cases:8.81%
controls:4.83%
cases:8.94%
controls:3.80%
cases:1.82%
controls:1.29%
—
—
cases:2.25%
controls:1.23%
cases:8.73%
controls:3.85%
cases:11.71%
controls:5.04%
63
334
652
6575
64
263
652
6652
13
89
703
6826
—
16
85
696
6823
60
262
627
6547
74
313
558
5898
hydrocortisone and antiinfectives
S02CA03 [21605175]
S02CA03 [21605175]
8.7e-01
7.8e-01
2.5e+00
—
-1.0e+50
1.0e+00
7.1e-01
cases:4.34%
controls:1.87%
cases:0.98%
controls:0.45%
cases:0.84%
controls:0.07%
—
—
cases:0.00%
controls:0.07%
cases:1.46%
controls:0.53%
cases:4.11%
controls:2.06%
31
129
684
6780
7
31
709
6884
6
5
710
6910
—
0
5
712
6903
10
36
677
6773
26
128
606
6083
hydrocortisone and antiinfectives
S03CA04 [21605208]
S03CA04 [21605208]
8.7e-01
7.8e-01
2.5e+00
—
-1.0e+50
1.0e+00
7.1e-01
cases:4.34%
controls:1.87%
cases:0.98%
controls:0.45%
cases:0.84%
controls:0.07%
—
—
cases:0.00%
controls:0.07%
cases:1.46%
controls:0.53%
cases:4.11%
controls:2.06%
31
129
684
6780
7
31
709
6884
6
5
710
6910
—
0
5
712
6903
10
36
677
6773
26
128
606
6083
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
6.6e-01
1.4e+00
—
—
—
1.1e+00
8.1e-01
cases:3.78%
controls:2.00%
cases:2.93%
controls:0.72%
—
—
—
—
—
—
cases:1.89%
controls:0.65%
cases:4.91%
controls:2.25%
27
138
688
6771
21
50
695
6865
—
—
—
13
44
674
6765
31
140
601
6071
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
4.0e-01
3.7e-01
1.4e+00
—
1.2e+00
6.1e-01
2.7e-01
cases:9.37%
controls:6.50%
cases:5.87%
controls:4.14%
cases:2.09%
controls:0.52%
—
—
cases:1.69%
controls:0.49%
cases:6.70%
controls:3.75%
cases:12.18%
controls:9.60%
67
449
648
6460
42
286
674
6629
15
36
701
6879
—
12
34
700
6874
46
255
641
6554
77
596
555
5615
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.2e+00
-6.7e-01
—
-1.0e+50
—
2.1e+00
3.1e+00
cases:8.95%
controls:24.59%
cases:4.33%
controls:8.16%
—
—
cases:0.00%
controls:0.12%
—
—
cases:2.62%
controls:0.34%
cases:12.97%
controls:0.69%
64
1699
651
5210
31
564
685
6351
—
0
8
716
6907
—
18
23
669
6786
82
43
550
6168
Multiple myeloma
C90.0 [45600562]
C90.0 [45600562]
—
—
—
1.0e+50
—
—
3.3e+00
—
—
—
—
—
—
cases:1.68%
controls:0.00%
—
—
—
—
cases:2.06%
controls:0.08%
—
—
—
12
0
704
6915
—
—
13
5
619
6206
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
8.6e-01
1.2e+00
—
—
—
9.9e-01
1.2e+00
cases:3.78%
controls:1.64%
cases:2.23%
controls:0.71%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:4.91%
controls:1.48%
27
113
688
6796
16
49
700
6866
—
—
—
10
37
677
6772
31
92
601
6119
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
5.8e-02
3.8e-01
1.2e+00
—
1.7e+00
2.6e-01
2.1e-01
cases:21.54%
controls:20.57%
cases:20.67%
controls:15.14%
cases:8.80%
controls:2.81%
—
—
cases:12.78%
controls:2.69%
cases:18.63%
controls:15.04%
cases:29.11%
controls:25.02%
154
1421
561
5488
148
1047
568
5868
63
194
653
6721
—
91
186
621
6722
128
1024
559
5785
184
1554
448
4657
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
4.1e-01
4.1e-01
1.4e+00
—
1.2e+00
6.2e-01
2.7e-01
cases:9.93%
controls:6.79%
cases:6.15%
controls:4.18%
cases:2.09%
controls:0.54%
—
—
cases:1.69%
controls:0.51%
cases:6.84%
controls:3.80%
cases:12.34%
controls:9.71%
71
469
644
6440
44
289
672
6626
15
37
701
6878
—
12
35
700
6873
47
259
640
6550
78
603
554
5608
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
4.4e-01
8.3e-01
1.6e+00
—
1.6e+00
8.0e-01
4.0e-01
cases:6.85%
controls:4.52%
cases:3.21%
controls:1.43%
cases:1.54%
controls:0.32%
—
—
cases:0.70%
controls:0.14%
cases:3.49%
controls:1.60%
cases:8.07%
controls:5.54%
49
312
666
6597
23
99
693
6816
11
22
705
6893
—
5
10
707
6898
24
109
663
6700
51
344
581
5867
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
4.4e-01
1.1e+00
—
—
—
1.2e+00
9.0e-01
cases:4.20%
controls:2.75%
cases:1.96%
controls:0.67%
—
—
—
—
—
—
cases:2.04%
controls:0.62%
cases:3.01%
controls:1.24%
30
190
685
6719
14
46
702
6869
—
—
—
14
42
673
6767
19
77
613
6134
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
6.0e-01
9.1e-01
—
—
2.5e+00
6.4e-01
7.3e-01
cases:3.92%
controls:2.19%
cases:1.68%
controls:0.68%
—
—
—
—
cases:0.84%
controls:0.07%
cases:1.16%
controls:0.62%
cases:5.22%
controls:2.59%
28
151
687
6758
12
47
704
6868
—
—
6
5
706
6903
8
42
679
6767
33
161
599
6050
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.4e-01
3.7e-01
1.4e+00
—
1.2e+00
5.9e-01
2.4e-01
cases:9.37%
controls:6.85%
cases:6.01%
controls:4.22%
cases:2.09%
controls:0.55%
—
—
cases:1.69%
controls:0.49%
cases:6.70%
controls:3.82%
cases:12.18%
controls:9.85%
67
473
648
6436
43
292
673
6623
15
38
701
6877
—
12
34
700
6874
46
260
641
6549
77
612
555
5599
allopurinol; oral, parenteral
M04AA01 [21604131]
M04AA01 [21604131]
9.9e-01
1.3e+00
—
—
—
9.2e-01
6.1e-01
cases:3.64%
controls:1.39%
cases:3.35%
controls:0.98%
—
—
—
—
—
—
cases:2.62%
controls:1.06%
cases:2.69%
controls:1.48%
26
96
689
6813
24
68
692
6847
—
—
—
18
72
669
6737
17
92
615
6119
Dry eye syndrome
H04.10 [2000502254]
H04.10 [2000502254]
1.2e+00
—
-1.0e+50
—
—
1.9e+00
9.5e-01
cases:1.82%
controls:0.55%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.02%
controls:0.15%
cases:2.22%
controls:0.87%
13
38
702
6871
—
0
6
716
6909
—
—
7
10
680
6799
14
54
618
6157
Gastroenterology
10 [38004455]
10 [38004455]
8.8e-01
7.9e-01
1.4e+00
—
—
1.2e+00
1.1e+00
cases:6.57%
controls:2.84%
cases:2.93%
controls:1.36%
cases:0.98%
controls:0.25%
—
—
—
—
cases:4.51%
controls:1.41%
cases:8.07%
controls:2.95%
47
196
668
6713
21
94
695
6821
7
17
709
6898
—
—
31
96
656
6713
51
183
581
6028
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.4e+00
1.6e+00
—
—
—
1.9e+00
1.4e+00
cases:1.26%
controls:0.30%
cases:1.12%
controls:0.22%
—
—
—
—
—
—
cases:0.87%
controls:0.13%
cases:1.90%
controls:0.47%
9
21
706
6888
8
15
708
6900
—
—
—
6
9
681
6800
12
29
620
6182
Transplant complication
127 [2001600125]
127 [2001600125]
3.1e+00
—
—
—
—
—
—
cases:1.82%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
13
6
702
6903
—
—
—
—
—
—
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
8.0e-02
4.1e-01
2.1e+00
—
1.8e+00
9.2e-01
4.5e-01
cases:2.24%
controls:2.07%
cases:1.68%
controls:1.11%
cases:0.84%
controls:0.10%
—
—
cases:0.70%
controls:0.12%
cases:2.47%
controls:1.00%
cases:3.32%
controls:2.14%
16
143
699
6766
12
77
704
6838
6
7
710
6908
—
5
8
707
6900
17
68
670
6741
21
133
611
6078
General Surgery
2 [38004447]
2 [38004447]
3.9e-01
6.1e-01
9.4e-01
—
1.4e+00
4.0e-01
4.6e-01
cases:17.76%
controls:12.74%
cases:6.70%
controls:3.76%
cases:1.40%
controls:0.55%
—
—
cases:1.69%
controls:0.41%
cases:5.68%
controls:3.88%
cases:18.20%
controls:12.30%
127
880
588
6029
48
260
668
6655
10
38
706
6877
—
12
28
700
6880
39
264
648
6545
115
764
517
5447
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
TPH20 [2001309601]
6.9e-01
2.9e+00
—
—
—
—
—
cases:0.98%
controls:0.49%
cases:1.26%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
7
34
708
6875
9
5
707
6910
—
—
—
—
—
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.3e-01
5.4e-01
6.2e-01
—
2.3e+00
4.9e-01
5.5e-01
cases:6.71%
controls:4.92%
cases:4.75%
controls:2.82%
cases:0.70%
controls:0.38%
—
—
cases:2.81%
controls:0.29%
cases:4.37%
controls:2.72%
cases:12.50%
controls:7.65%
48
340
667
6569
34
195
682
6720
5
26
711
6889
—
20
20
692
6888
30
185
657
6624
79
475
553
5736
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
2.6e-01
4.2e-01
7.1e-01
2.3e+00
1.3e+00
2.6e-01
4.0e-01
cases:22.94%
controls:18.67%
cases:15.50%
controls:10.76%
cases:4.61%
controls:2.33%
cases:0.70%
controls:0.07%
cases:6.46%
controls:1.85%
cases:13.97%
controls:11.15%
cases:29.91%
controls:22.23%
164
1290
551
5619
111
744
605
6171
33
161
683
6754
5
5
711
6910
46
128
666
6780
96
759
591
6050
189
1381
443
4830
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.7e-02
4.6e-01
1.3e+00
—
1.5e+00
3.5e-01
3.3e-01
cases:10.49%
controls:10.33%
cases:8.66%
controls:5.64%
cases:3.21%
controls:0.91%
—
—
cases:3.51%
controls:0.78%
cases:7.13%
controls:5.13%
cases:14.72%
controls:11.06%
75
714
640
6195
62
390
654
6525
23
63
693
6852
—
25
54
687
6854
49
349
638
6460
93
687
539
5524
filgrastim; parenteral
L03AA02 [21603851]
L03AA02 [21603851]
1.5e+00
—
—
—
—
—
2.8e+00
cases:0.84%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.58%
controls:0.10%
6
13
709
6896
—
—
—
—
—
10
6
622
6205
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
4.0e-01
7.0e-01
7.5e-01
—
1.6e+00
1.2e+00
3.6e-01
cases:2.94%
controls:2.00%
cases:2.09%
controls:1.06%
cases:0.70%
controls:0.33%
—
—
cases:1.69%
controls:0.36%
cases:3.06%
controls:0.93%
cases:3.01%
controls:2.13%
21
138
694
6771
15
73
701
6842
5
23
711
6892
—
12
25
700
6883
21
63
666
6746
19
132
613
6079
nystatin; oral
A07AA02 [21600604]
A07AA02 [21600604]
9.4e-01
1.9e+00
—
—
—
2.8e+00
1.3e+00
cases:1.40%
controls:0.55%
cases:0.84%
controls:0.13%
—
—
—
—
—
—
cases:1.60%
controls:0.10%
cases:1.42%
controls:0.39%
10
38
705
6871
6
9
710
6906
—
—
—
11
7
676
6802
9
24
623
6187
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
5.1e-01
6.1e-01
1.2e+00
—
2.0e+00
7.8e-01
3.6e-01
cases:6.15%
controls:3.78%
cases:3.91%
controls:2.17%
cases:1.12%
controls:0.33%
—
—
cases:2.25%
controls:0.32%
cases:3.78%
controls:1.78%
cases:7.12%
controls:5.06%
44
261
671
6648
28
150
688
6765
8
23
708
6892
—
16
22
696
6886
26
121
661
6688
45
314
587
5897
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
—
2.7e+00
—
—
1.0e+50
1.7e+00
1.4e+00
—
—
cases:1.12%
controls:0.07%
—
—
—
—
cases:0.98%
controls:0.00%
cases:0.73%
controls:0.13%
cases:1.42%
controls:0.34%
—
8
5
708
6910
—
—
7
0
705
6908
5
9
682
6800
9
21
623
6190
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
80223-1 [21494815]
—
2.1e+00
—
—
—
—
2.7e+00
—
—
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.13%
—
5
6
711
6909
—
—
—
—
12
8
620
6203
Vascular Surgery
77 [38004496]
77 [38004496]
4.8e-01
1.1e+00
—
—
—
1.5e+00
5.0e-01
cases:2.38%
controls:1.49%
cases:1.82%
controls:0.59%
—
—
—
—
—
—
cases:2.77%
controls:0.60%
cases:2.69%
controls:1.64%
17
103
698
6806
13
41
703
6874
—
—
—
19
41
668
6768
17
102
615
6109
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
5.2e-01
7.3e-01
1.7e+00
—
—
9.3e-01
5.7e-01
cases:4.62%
controls:2.79%
cases:2.51%
controls:1.23%
cases:1.40%
controls:0.25%
—
—
—
—
cases:2.91%
controls:1.17%
cases:4.43%
controls:2.56%
33
193
682
6716
18
85
698
6830
10
17
706
6898
—
—
20
80
667
6729
28
159
604
6052
Bloodpressure monitoring
XF602 [2001303378]
XF602 [2001303378]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.58%
controls:0.11%
—
—
—
—
—
—
10
7
622
6204
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
3.5e-01
8.0e-01
1.3e+00
—
1.8e+00
3.1e-01
3.2e-01
cases:6.71%
controls:4.85%
cases:5.17%
controls:2.40%
cases:1.12%
controls:0.30%
—
—
cases:1.97%
controls:0.32%
cases:3.35%
controls:2.47%
cases:8.86%
controls:6.59%
48
335
667
6574
37
166
679
6749
8
21
708
6894
—
14
22
698
6886
23
168
664
6641
56
409
576
5802
CD8 cells/Lymphocytes in Specimen
80222-3 [21494814]
80222-3 [21494814]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.08%
—
—
—
—
—
—
7
5
625
6206
CD19 cells/cells in Blood
8117-4 [3016228]
8117-4 [3016228]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.08%
—
—
—
—
—
—
7
5
625
6206
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.5e-01
8.8e-01
1.4e+00
—
1.7e+00
9.6e-01
7.7e-01
cases:4.20%
controls:2.71%
cases:2.65%
controls:1.11%
cases:0.84%
controls:0.20%
—
—
cases:0.70%
controls:0.13%
cases:2.77%
controls:1.07%
cases:5.06%
controls:2.42%
30
187
685
6722
19
77
697
6838
6
14
710
6901
—
5
9
707
6899
19
73
668
6736
32
150
600
6061
pegfilgrastim; parenteral
L03AA13 [21603856]
L03AA13 [21603856]
—
2.6e+00
—
—
—
—
—
—
—
cases:0.98%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
7
5
709
6910
—
—
—
—
—
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
1.9e-01
1.1e+00
—
—
—
1.4e+00
1.2e+00
cases:0.98%
controls:0.81%
cases:1.40%
controls:0.49%
—
—
—
—
—
—
cases:1.60%
controls:0.40%
cases:2.22%
controls:0.71%
7
56
708
6853
10
34
706
6881
—
—
—
11
27
676
6782
14
44
618
6167
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
5.4e-01
7.5e-01
1.1e+00
—
4.9e-01
5.9e-01
6.5e-01
cases:6.29%
controls:3.76%
cases:6.56%
controls:3.21%
cases:2.93%
controls:0.95%
—
—
cases:1.69%
controls:1.04%
cases:5.68%
controls:3.23%
cases:7.12%
controls:3.86%
45
260
670
6649
47
222
669
6693
21
66
695
6849
—
12
72
700
6836
39
220
648
6589
45
240
587
5971
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
24467-3 [3028167]
—
2.3e+00
—
—
—
2.5e+00
2.1e+00
—
—
cases:0.70%
controls:0.07%
—
—
—
—
—
—
cases:0.87%
controls:0.07%
cases:0.79%
controls:0.10%
—
5
5
711
6910
—
—
—
6
5
681
6804
5
6
627
6205
Bronchial lavation
TGC00 [2001303585]
TGC00 [2001303585]
1.7e+00
—
—
—
—
—
2.5e+00
cases:0.70%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.08%
5
9
710
6900
—
—
—
—
—
6
5
626
6206
Very extensive body CT
JN4CD [2001310902]
JN4CD [2001310902]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.08%
—
—
—
—
—
—
6
5
626
6206
CD19 cells [#/volume] in Blood
8116-6 [3010503]
8116-6 [3010503]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.10%
—
—
—
—
—
—
7
6
625
6205
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
1.1e+00
1.2e+00
—
—
—
1.3e+00
4.5e-01
cases:2.10%
controls:0.69%
cases:1.54%
controls:0.45%
—
—
—
—
—
—
cases:1.89%
controls:0.51%
cases:2.85%
controls:1.84%
15
48
700
6861
11
31
705
6884
—
—
—
13
35
674
6774
18
114
614
6097
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
7.9e-01
—
—
—
—
—
2.4e+00
cases:0.98%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.11%
7
31
708
6878
—
—
—
—
—
8
7
624
6204
sulfasalazine; oral, rectal
A07EC01 [21600663]
A07EC01 [21600663]
1.2e+00
1.1e+00
—
—
—
1.2e+00
1.2e+00
cases:2.24%
controls:0.67%
cases:1.68%
controls:0.58%
—
—
—
—
—
—
cases:1.60%
controls:0.48%
cases:2.06%
controls:0.63%
16
46
699
6863
12
40
704
6875
—
—
—
11
33
676
6776
13
39
619
6172
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
-3.5e-02
2.1e-01
1.3e+00
—
1.1e+00
-2.3e-02
1.8e-01
cases:20.42%
controls:21.00%
cases:11.17%
controls:9.28%
cases:3.77%
controls:1.07%
—
—
cases:3.79%
controls:1.24%
cases:9.46%
controls:9.66%
cases:28.96%
controls:25.49%
146
1451
569
5458
80
642
636
6273
27
74
689
6841
—
27
86
685
6822
65
658
622
6151
183
1583
449
4628
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
-3.5e-02
2.1e-01
1.3e+00
—
1.1e+00
-2.3e-02
1.8e-01
cases:20.42%
controls:21.00%
cases:11.17%
controls:9.28%
cases:3.77%
controls:1.07%
—
—
cases:3.79%
controls:1.24%
cases:9.46%
controls:9.66%
cases:28.96%
controls:25.49%
146
1451
569
5458
80
642
636
6273
27
74
689
6841
—
27
86
685
6822
65
658
622
6151
183
1583
449
4628
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
50
95
5.37
25.19
40.0
27.5
95.67
132.18
ug/l
2.96
44
69
371
2150
1.89
24.69
13.1
7.9
1.07
1.07
mmol/l
0.11
357
2039
99
330
3.11
23.23
7.7
3.9
6625.36
1998.39
u/ml
0.37
11
23
114
418
2.83
22.58
10.0
7.2
773.73
533.53
iu/ml
0.21
22
55
42
82
5.21
20.55
1.2
1.2
—
—
—
0
0
284
1652
1.84
18.28
11.1
5.2
1.24
1.64
mmol/l
1.42
252
1435
288
1691
1.82
17.97
11.0
5.2
5.77
5.84
kpa
0.72
281
1654
844
6493
1.53
17.95
8.0
5.8
36.35
36.80
g/l
1.42
815
6144
43
98
4.46
17.57
1.2
1.1
—
—
—
0
0
255
1454
1.87
17.45
10.2
4.6
4.69
4.74
kpa
0.14
249
1422
213
1156
1.95
16.92
4.4
3.3
71.19
71.87
e9/l
0.09
163
837
149
710
2.19
16.83
12.5
6.5
1.51
1.32
mg/l
1.59
144
672
77
270
2.93
16.58
2.3
1.7
—
—
—
0
0
278
1682
1.76
15.56
7.4
5.0
251.89
239.00
u/l
0.62
267
1620
53
154
3.51
15.56
1.5
1.8
—
—
—
0
0
247
1456
1.80
15.09
4.9
2.7
10.12
10.54
g/l
0.63
224
1350
29
54
5.44
14.96
3.3
2.9
0.57
0.60
mmol/l
1.15
29
54
899
7209
1.46
14.53
14.2
8.3
1.21
1.21
mmol/l
0.68
795
6353
390
2628
1.60
14.42
7.7
4.6
0.80
0.82
mmol/l
1.34
372
2515
1071
8898
1.45
14.21
11.7
7.0
1.91
2.01
e9/l
1.70
986
7919
49
144
3.46
14.16
2.5
2.3
—
—
—
0
0
364
2441
1.60
13.66
3.3
2.7
29.67
29.50
s
0.22
355
2381
1129
9519
1.44
13.53
15.6
10.1
3.96
4.06
e9/l
0.73
1015
8275
96
417
2.37
13.51
1.7
1.8
66.00
7.32
e6/l
1.79
69
311
977
8034
1.43
13.37
9.9
6.9
12.29
11.89
umol/l
0.31
936
7679
58
197
3.00
13.26
1.3
1.2
—
—
—
0
0
1072
8974
1.43
13.23
12.3
7.4
0.19
0.20
e9/l
0.33
982
7919
56
187
3.05
13.19
1.1
1.1
—
—
—
0
0
175
978
1.87
12.66
8.8
4.9
96.40
84.60
ng/l
0.85
165
890
1116
9458
1.42
12.56
8.8
5.6
6.77
6.68
mmol/l
0.59
1072
8909
244
1508
1.71
12.55
16.8
9.6
9.41
8.22
mmol/l
1.91
239
1459
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
89
3.99
12.47
1.2
1.1
—
—
—
0
0
95
426
2.29
12.45
1.8
1.9
1234.03
1144.97
e6/l
0.03
72
334
804
6448
1.42
12.32
14.2
7.9
1.21
1.21
mmol/l
0.25
770
6056
70
276
2.59
12.13
2.3
2.0
—
—
—
0
0
52
177
2.99
11.87
1.7
2.0
—
—
—
0
0
123
624
2.04
11.81
5.6
3.9
3.40
3.56
g/l
0.51
117
606
818
6615
1.41
11.79
12.9
10.9
1.17
1.17
inr
0.01
698
5466
94
430
2.25
11.76
2.1
1.9
—
—
—
0
0
842
6846
1.40
11.75
3.4
2.5
71.62
71.98
nmol/l
0.14
789
6399
925
7645
1.40
11.71
17.7
11.0
0.01
0.00
e9/l
0.52
797
6257
31
77
4.07
11.41
1.8
1.9
—
—
—
0
0
366
2553
1.53
11.39
4.7
2.7
13.89
14.34
umol/l
0.53
349
2417
57
210
2.77
11.29
1.1
1.1
—
—
—
0
0
165
946
1.81
10.99
10.1
4.0
129.61
133.73
g/l
1.55
158
930
27
63
4.33
10.77
1.1
1.1
—
—
—
0
0
456
3369
1.46
10.63
4.2
2.7
5.12
4.86
e6/l
0.14
427
3070
176
1043
1.76
10.49
5.7
2.6
65.75
67.13
g/l
1.37
166
988
319
2198
1.54
10.43
4.9
2.7
24.15
24.35
%
0.08
304
2093
187
1135
1.72
10.24
3.3
1.8
1.36
1.31
g/l
0.10
172
1063
1361
12157
1.39
9.92
12.1
7.9
82.81
79.21
u/l
1.57
1321
11645
58
231
2.56
9.90
6.3
4.0
0.69
1.44
%
2.60
51
216
88
421
2.14
9.90
2.1
1.8
—
—
—
0
0
56
221
2.58
9.75
2.4
1.6
—
—
—
0
0
556
4330
1.40
9.52
5.4
3.2
0.30
0.40
e6/l
0.60
443
3106
75
346
2.21
9.26
1.3
1.1
—
—
—
0
0
170
1034
1.71
9.23
7.9
4.3
1.22
1.23
mmol/l
1.16
156
905
195
1230
1.65
9.23
5.8
4.3
5.07
5.12
kpa
0.53
187
1189
43
153
2.85
9.14
1.8
2.2
—
—
—
0
0
43
153
2.85
9.14
2.3
3.0
198.61
222.57
e6/l
0.26
33
127
212
1372
1.61
9.05
3.7
3.1
—
—
—
0
0
321
2280
1.49
9.01
2.3
1.9
—
—
—
0
0
80
386
2.12
8.84
1.6
1.3
—
—
—
0
0
625
5014
1.36
8.78
5.5
3.3
36.31
89.55
e6/l
1.29
512
3784
231
1537
1.57
8.77
3.2
2.8
0.22
0.22
g/l
0.03
213
1450
37
124
3.02
8.75
2.8
2.9
33.02
41.48
%
1.62
12
58
36
120
3.04
8.59
1.8
1.9
—
—
—
0
0
332
2398
1.46
8.53
4.8
2.6
2.34
2.38
g/l
0.56
315
2252
541
4259
1.37
8.52
7.5
4.6
90.62
90.91
%
0.11
530
4181
41
148
2.81
8.51
2.3
3.0
580.48
568.98
e6/l
0.03
31
118
184
1174
1.63
8.32
2.4
2.4
8.96
17.67
au/ml
4.51
23
151
503
3930
1.38
8.26
2.1
1.5
2.21
2.38
g/l
0.99
334
2540
75
364
2.10
8.18
1.9
1.5
—
—
—
0
0
248
1703
1.52
8.16
2.1
1.8
—
—
—
0
0
32
103
3.14
8.11
1.8
1.2
—
—
—
0
0
172
1088
1.64
8.05
1.3
1.3
29.91
51.79
au/ml
—
10
75
86
444
1.98
7.94
2.1
1.6
104.76
141.79
au/ml
1.65
23
149
556
4438
1.35
7.92
4.4
2.7
353.56
350.68
umol/l
0.28
515
4087
688
5680
1.33
7.76
4.6
3.6
8.64
8.93
mmol/l
0.76
602
4993
168
1068
1.63
7.72
6.0
4.3
1.51
1.28
mmol/l
0.42
130
776
62
286
2.21
7.70
1.6
1.3
—
—
—
0
0
62
286
2.21
7.70
1.6
1.3
—
—
—
0
0
144
884
1.68
7.58
1.9
1.6
5.33
6.52
u/l
1.38
120
681
14
14
10.06
7.53
4.5
5.3
—
—
—
0
0
105
590
1.82
7.52
2.9
2.0
1.38
1.40
g/l
0.07
96
516
158
997
1.64
7.48
2.4
1.7
—
—
—
0
0
613
4999
1.33
7.48
3.2
2.8
58.69
61.12
u/l
0.53
580
4714
485
3827
1.36
7.37
2.8
2.3
2.86
2.65
mg/l
1.22
437
3371
604
4928
1.33
7.31
5.2
4.3
11.69
9.47
mg/mmol
0.56
416
3360
234
1624
1.50
7.30
2.3
1.9
—
—
—
0
0
63
300
2.14
7.25
2.0
1.5
—
—
—
0
0
106
606
1.79
7.19
5.0
2.6
1.02
1.02
ratio
0.60
99
554
680
5660
1.31
7.08
4.2
3.2
55.20
54.41
ng/l
0.02
491
3525
63
304
2.11
7.02
1.8
1.5
—
—
—
0
0
31
107
2.93
7.02
4.1
3.5
1151.29
656.61
u/ml
1.04
31
107
236
1658
1.48
6.93
2.8
2.4
356.36
369.64
nmol/l
0.55
228
1567
1306
11854
1.30
6.93
5.8
4.0
10.58
9.05
mm/h
3.47
1247
11244
176
1167
1.56
6.78
3.1
2.4
0.34
0.26
e6/l
0.32
165
1117
127
787
1.66
6.48
1.7
1.6
—
—
—
0
0
50
228
2.22
6.44
2.3
1.7
—
—
—
0
0
574
4719
1.31
6.42
3.8
3.5
2.35
2.35
mmol/l
0.52
539
4388
14
19
7.41
6.41
3.4
4.6
—
—
—
0
0
260
1889
1.43
6.40
1.8
1.7
1100.96
1119.09
nmol/l
0.12
218
1491
72
384
1.91
6.12
10.5
3.2
57.77
64.24
mg/l
0.11
61
319
72
384
1.91
6.12
10.5
3.2
71.12
32.87
mg/l
0.77
61
318
717
6097
1.28
6.12
4.9
3.6
46.27
37.45
u/l
0.26
681
5773
10
8
12.56
6.08
5.2
9.3
—
—
—
0
0
73
393
1.89
6.04
5.6
2.3
1.84
0.53
g/l
1.16
66
353
351
2714
1.36
5.96
4.7
2.9
1.12
0.82
e6/l
0.40
209
1366
91
527
1.76
5.96
2.3
1.5
0.23
0.24
g/l
0.70
84
502
330
2533
1.36
5.87
4.8
3.0
2.65
1.65
e6/l
0.86
182
1185
902
7913
1.26
5.85
4.4
3.1
157.12
127.99
ug/l
0.96
858
7564
114
707
1.65
5.82
1.6
1.4
—
—
—
0
0
559
4631
1.29
5.80
2.6
2.3
212.54
254.68
u/l
0.43
540
4438
115
716
1.64
5.79
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
83
475
1.78
5.67
8.9
4.4
0.33
0.35
iu/ml
0.12
47
248
49
234
2.12
5.67
2.0
1.5
—
—
—
0
0
973
8632
1.25
5.65
4.7
3.3
5.90
5.50
estimate
0.02
239
1731
106
652
1.66
5.60
2.4
1.7
6.66
5.94
iu/ml
0.09
27
157
90
530
1.73
5.58
2.3
2.1
2.08
1.46
ug/l
0.37
81
488
456
3697
1.30
5.55
4.5
3.2
1411.42
1005.85
ng/l
0.71
382
3027
20
62
3.25
5.45
10.2
3.8
1.10
1.30
%
0.25
20
62
1752
16770
1.42
5.36
23.7
15.4
3.98
3.97
mmol/l
0.20
1734
16430
25
90
2.80
5.31
2.3
1.6
—
—
—
0
0
466
3809
1.29
5.30
3.7
2.5
—
—
—
0
0
166
1150
1.48
5.25
1.2
1.3
156.31
138.42
u/ml
0.27
64
426
177
1243
1.47
5.22
3.4
2.5
70.44
75.67
ml/min/173m2
0.79
77
469
21
69
3.07
5.22
1.3
1.1
—
—
—
0
0
1659
15757
1.34
5.19
18.6
12.5
88.81
89.56
ml/min/173m2
0.71
1552
14350
70
393
1.81
5.13
3.7
2.9
2.32
2.04
index
0.20
41
228
971
8675
1.24
5.08
4.7
3.3
0.05
0.20
estimate
0.39
228
1603
959
8559
1.24
5.06
4.7
3.3
0.00
0.00
estimate
0.50
238
1735
86
516
1.70
5.02
1.7
1.4
314.21
231.41
u/ml
1.14
53
297
47
236
2.02
4.81
6.0
6.9
10.50
10.70
mg/l
0.10
39
221
28
113
2.50
4.80
4.5
2.7
1050.96
1318.76
mg
0.40
28
113
1741
16705
1.37
4.71
23.3
15.3
139.64
139.66
mmol/l
0.10
1724
16401
78
466
1.70
4.64
2.7
2.5
—
—
—
0
0
837
7411
1.23
4.62
3.8
2.8
—
—
estimate
—
0
0
452
3740
1.27
4.60
2.6
2.0
1.33
1.08
mg/l
0.43
363
2848
709
6192
1.23
4.42
2.2
1.9
95.29
95.63
pmol/l
0.07
431
3529
310
2456
1.31
4.41
3.1
3.0
159.20
127.02
ug/g
0.61
262
2033
33
151
2.21
4.31
4.0
3.9
56.68
56.97
%
0.02
28
139
255
1971
1.34
4.31
6.2
3.2
9.01
7.93
umol/l
0.30
222
1729
348
2811
1.29
4.27
2.6
2.4
13.78
14.10
nmol/l
0.36
331
2635
30
133
2.28
4.23
1.8
2.6
—
—
—
0
0
37
179
2.09
4.22
1.3
1.3
—
—
—
0
0
23
91
2.55
4.13
3.2
1.5
18.55
8.29
ug/l
0.34
23
83
526
4479
1.24
4.12
4.5
3.4
0.01
0.01
estimate
0.13
217
1606
60
346
1.76
4.08
11.2
3.0
4.89
2.08
ratio
0.36
36
195
55
309
1.80
4.08
3.7
2.5
17.13
17.09
%
0.03
55
301
28
123
2.29
4.04
1.9
2.0
—
—
—
0
0
28
123
2.29
4.04
1.9
2.0
—
—
—
0
0
28
123
2.29
4.04
1.9
2.0
—
—
—
0
0
211
1601
1.36
4.03
3.0
2.7
35.87
70.84
u/l
0.63
192
1390
52
289
1.82
4.00
1.9
1.6
—
—
—
0
0
77
480
1.63
3.95
3.1
2.4
11.02
11.11
mg/l
0.03
71
455
13
32
4.08
3.90
1.7
1.9
—
—
—
0
0
1333
12473
1.21
3.87
4.4
3.8
14.66
14.54
pmol/l
1.05
1264
11659
1739
16767
1.33
3.84
21.7
13.5
22.14
23.45
mg/l
1.01
1485
13487
21
83
2.55
3.80
2.6
1.7
—
—
—
0
0
21
83
2.55
3.80
2.9
2.1
—
—
—
0
0
21
83
2.55
3.80
2.9
2.1
—
—
—
0
0
14
38
3.70
3.79
1.2
1.1
—
—
—
0
0
439
3699
1.24
3.75
1.9
1.6
18.39
19.66
nmol/l
1.12
391
3251
1064
9777
1.19
3.65
5.4
3.9
3916.64
721.77
e6/l
0.37
11
108
159
1172
1.39
3.65
3.9
4.8
15.14
30.80
ug/l
0.74
132
947
16
56
2.87
3.63
2.9
6.1
—
—
—
0
0
126
893
1.44
3.61
1.8
1.6
12.71
19.71
iu/l
2.46
99
714
19
74
2.58
3.55
1.2
1.1
98.20
186.00
ng/l
—
10
22
48
271
1.79
3.55
2.3
2.4
15.87
27.01
iu/ml
—
7
25
24
106
2.28
3.46
4.5
5.1
8.55
9.25
mg/l
0.26
19
94
1366
12873
1.20
3.42
4.5
3.5
50.40
48.64
u/l
0.32
1316
12391
14
47
2.99
3.41
2.1
1.7
—
—
—
0
0
57
343
1.68
3.39
4.8
2.1
0.00
0.00
g/l
-0.00
52
301
20
82
2.45
3.38
2.7
1.6
—
—
—
0
0
8
14
5.73
3.34
2.0
1.4
—
—
—
0
0
40
218
1.85
3.33
1.4
1.3
—
—
—
0
0
334
2771
1.25
3.26
1.7
1.7
30208766.79
35507062.28
pmol/l
0.06
288
2408
25
116
2.17
3.22
2.6
1.6
—
—
—
0
0
69
442
1.58
3.22
2.1
1.8
—
—
—
0
0
73
475
1.56
3.19
1.4
1.4
264.56
275.63
ug/g
0.17
36
279
7
11
6.38
3.18
2.1
2.1
—
—
—
0
0
53
319
1.68
3.17
1.7
1.6
—
—
—
0
0
96
665
1.47
3.14
5.2
6.0
1.52
1.73
%
1.16
91
622
10
25
4.02
3.08
6.7
7.7
4.71
7.52
mmol/l
—
10
25
7
12
5.85
3.02
2.3
1.3
—
—
—
0
0
30
154
1.96
3.00
1.1
1.1
—
—
—
0
0
44
257
1.73
2.95
3.5
2.8
10.11
7.59
umol/l
0.51
35
198
166
1281
1.32
2.88
1.6
1.3
389.34
260.74
u/ml
0.50
154
1198
12
38
3.17
2.85
1.5
1.4
13.23
17.39
pmol/l
—
6
17
13
47
2.78
2.81
1.2
1.1
—
—
—
0
0
20
90
2.23
2.80
3.4
3.7
189.42
144.53
umol/l
0.28
12
47
565
5005
1.18
2.78
4.0
2.7
0.03
0.07
estimate
0.50
196
1398
1828
17864
1.34
2.75
15.9
10.9
30.19
30.18
u/l
0.01
1795
17510
8
19
4.22
2.68
2.9
2.3
—
—
—
0
0
37
212
1.76
2.68
1.5
1.4
—
—
—
0
0
731
6631
1.16
2.65
4.4
3.1
0.01
0.02
estimate
0.02
202
1467
47
290
1.64
2.61
1.8
1.5
0.55
0.32
nmol/l
0.63
38
228
7
15
4.68
2.59
2.1
1.9
—
—
—
0
0
216
1755
1.26
2.55
1.6
1.6
—
—
—
0
0
194
1556
1.27
2.55
13.0
11.4
95.48
95.91
%
0.44
189
1501
13
50
2.61
2.53
1.2
1.1
—
—
—
0
0
8
21
3.82
2.46
1.1
1.1
—
—
—
0
0
8
21
3.82
2.46
1.5
1.0
—
—
—
0
0
211
1718
1.26
2.45
12.6
10.9
12.12
12.68
kpa
0.79
201
1658
211
1718
1.26
2.45
12.6
10.9
5.01
5.14
kpa
1.14
202
1655
209
1700
1.26
2.45
12.8
10.9
0.25
0.77
mmol/l
0.91
165
1430
17
76
2.25
2.44
1.1
1.0
—
—
—
0
0
10
32
3.14
2.43
1.3
1.5
—
—
—
0
0
31
174
1.79
2.42
1.1
1.1
—
—
—
0
0
22
110
2.01
2.41
1.0
1.0
1.52
1.09
u/l
—
10
51
25
133
1.89
2.31
1.2
1.3
0.62
0.57
ratio
0.44
14
76
53
349
1.53
2.28
3.3
2.3
130.05
135.55
g/l
0.84
44
277
6
13
4.63
2.27
1.2
1.1
—
—
—
0
0
135
1051
1.31
2.25
1.1
1.1
—
—
—
0
0
25
135
1.86
2.22
3.2
3.9
—
—
—
0
0
14
60
2.34
2.22
3.7
2.4
39.36
92.81
ug/l
2.96
14
60
122
939
1.32
2.22
3.6
3.0
198.92
136.53
ng/l
1.01
108
838
103
774
1.35
2.20
2.7
2.2
41.46
39.85
u/l
0.33
93
701
12
48
2.51
2.18
1.3
1.1
—
—
—
0
0
25
136
1.85
2.18
1.4
1.2
—
—
—
0
0
7
19
3.69
2.15
6.4
8.8
—
—
—
0
0
65
456
1.44
2.09
1.4
1.2
8.40
2.92
u/ml
—
5
39
1561
15089
1.17
2.08
5.2
4.5
1.84
1.82
mu/l
0.37
1492
14244
27
153
1.78
2.08
1.3
1.1
—
68.70
—
0
10
115
888
1.31
2.06
1.9
1.7
314.77
297.25
mu/l
0.26
108
824
7
20
3.51
2.05
1.1
1.3
—
—
—
0
0
486
4348
1.16
2.05
1.5
1.4
1.43
2.45
u/ml
1.47
130
1205
25
139
1.81
2.05
1.5
1.2
—
—
—
0
0
46
302
1.54
2.04
1.3
1.2
—
—
—
0
0
234
2763
0.83
2.03
2.2
2.0
3.78
3.70
ratio
0.32
185
2155
285
2445
1.19
2.01
2.6
3.0
2.43
2.43
mmol/l
0.14
261
2183
25
140
1.80
2.01
1.5
1.2
—
—
—
0
0
72
519
1.40
2.00
3.5
4.0
821.02
2941.29
u/ml
0.55
61
461
51
348
1.48
1.91
1.3
1.2
2.00
3.48
u/ml
1.10
19
128
13
58
2.25
1.91
2.0
3.5
1.59
1.89
ratio
0.32
13
53
12
52
2.32
1.87
1.3
1.1
—
—
—
0
0
41
268
1.54
1.87
1.9
1.6
368.03
330.71
mu/l
0.50
35
217
64
458
1.41
1.87
1.4
1.2
7.67
7.08
u/ml
—
9
60
8
28
2.86
1.86
1.6
1.1
—
—
—
0
0
64
460
1.40
1.83
2.2
1.9
—
—
—
0
0
12
53
2.27
1.80
1.3
1.2
89.92
94.32
%
0.15
12
53
124
988
1.27
1.79
2.0
2.0
213.62
209.61
pmol/l
0.16
119
944
25
147
1.71
1.74
1.5
1.1
—
—
—
0
0
23
132
1.75
1.74
1.5
1.2
—
—
—
0
0
5
13
3.85
1.71
4.8
2.8
25.20
28.62
umol/l
—
5
13
28
171
1.65
1.70
1.6
2.2
31.96
32.87
pg
0.43
28
171
11
48
2.30
1.70
1.7
3.1
—
—
—
0
0
11
48
2.30
1.70
1.7
3.1
—
—
—
0
0
11
48
2.30
1.70
1.7
3.1
—
—
—
0
0
14
68
2.07
1.70
1.7
2.6
—
—
—
0
0
14
68
2.07
1.70
1.7
2.6
—
—
—
0
0
14
68
2.07
1.70
1.7
2.6
—
—
—
0
0
14
68
2.07
1.70
1.7
2.6
—
—
—
0
0
20
111
1.81
1.68
1.2
1.1
1657.75
1490.81
miu/ml
0.21
20
111
24
141
1.71
1.68
1.3
1.7
11.71
12.27
umol/l
0.21
24
131
23
135
1.71
1.62
3.4
2.8
0.89
0.87
nmol/l
0.07
16
110
5
14
3.58
1.61
4.8
2.6
38.20
34.57
umol/l
—
5
14
6
20
3.01
1.58
1.3
1.2
—
—
—
0
0
53
380
1.41
1.58
1.2
1.1
21.13
13.64
au/ml
—
10
109
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
1821
17927
1.22
1.49
25.2
16.4
80.85
77.12
umol/l
3.23
1808
17767
43
302
1.43
1.45
3.1
3.4
24.74
27.96
mg/l
0.27
27
200
20
117
1.72
1.45
2.9
1.9
—
—
—
0
0
11
52
2.12
1.44
1.6
1.4
85.27
98.31
nmol/24h
0.26
11
52
13
66
1.98
1.43
2.5
2.5
1.88
1.75
mmol/l
—
8
53
48
346
1.40
1.41
1.2
1.2
4.50
4.52
u/ml
0.00
22
165
20
119
1.69
1.37
2.0
1.5
39.62
29.43
%
0.57
14
82
26
166
1.57
1.37
1.5
1.2
—
—
—
0
0
6
23
2.61
1.36
1.2
1.8
—
—
—
0
0
42
299
1.41
1.34
1.2
1.2
—
437.14
—
0
7
20
121
1.66
1.30
1.3
1.2
101.05
108.88
pmol/l
0.25
20
121
65
502
1.30
1.26
2.4
2.1
—
—
—
0
0
113
934
1.22
1.25
3.8
3.5
4.59
4.70
pmol/l
0.66
106
856
13
70
1.86
1.24
1.2
1.2
—
78.00
—
0
10
56
425
1.33
1.23
1.3
1.3
—
—
—
0
0
12
63
1.91
1.22
1.2
1.1
102.83
93.80
%
—
6
35
12
63
1.91
1.22
1.2
1.0
93.67
94.63
%
—
6
35
24
156
1.55
1.20
2.3
1.7
52.22
55.88
%
0.17
18
113
62
480
1.30
1.19
1.7
2.1
1.02
0.84
nmol/l
0.61
54
416
1581
15454
1.12
1.19
6.7
5.6
39.40
38.75
mmol/mol
1.89
1514
14866
13
71
1.84
1.19
1.2
1.1
—
—
—
0
0
327
2960
1.13
1.17
1.3
1.3
32.64
27.45
iu/ml
0.29
96
885
10
50
2.01
1.16
2.9
2.3
—
—
—
0
0
17
102
1.67
1.16
2.1
4.3
0.52
1.63
ug/l
3.82
17
97
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
187
1633
1.16
1.14
4.7
4.2
30.52
30.21
%
0.17
147
1186
7
30
2.34
1.12
1.1
1.4
1.21
1.18
mmol/l
—
7
30
179
1564
1.16
1.09
7.0
5.6
—
—
—
0
0
22
144
1.53
1.08
1.5
1.7
—
—
—
0
0
55
426
1.30
1.08
1.2
1.1
—
—
—
0
0
101
842
1.21
1.06
2.3
2.4
11283.76
5615.92
u/l
0.59
38
312
37
272
1.37
1.03
1.6
1.4
167.88
204.52
pmol/l
0.47
37
272
9
47
1.92
1.02
1.9
2.2
41.61
41.83
g/l
—
9
47
49
379
1.30
0.99
2.3
1.6
18900.26
11466.57
e6/l
0.48
43
280
21
140
1.51
0.97
2.2
1.4
26941.38
98758.52
e6/l
0.69
16
99
19
124
1.54
0.96
1.1
1.2
—
—
—
0
0
1593
15630
1.10
0.94
4.9
4.4
5.97
5.91
mmol/l
0.82
1517
14750
11
62
1.78
0.94
3.9
2.5
120.55
117.85
ng/l
0.03
11
62
9
52
1.73
0.92
1.8
1.3
11.09
8.96
ug/l
—
9
52
54
428
1.27
0.92
1.2
1.1
—
—
—
0
0
6
28
2.15
0.91
2.0
1.6
—
—
—
0
0
65
528
1.24
0.90
1.1
1.1
4.52
6.16
u/ml
0.45
34
313
104
887
1.18
0.89
7.2
8.2
23.75
24.54
mmol/l
1.37
98
844
185
2070
0.88
0.88
1.9
1.7
3.42
3.47
mmol/l
0.26
135
1450
67
549
1.23
0.87
1.2
1.2
2.84
3.66
—
9
85
294
2698
1.11
0.85
1.3
1.3
11.14
9.96
u/ml
0.10
118
1112
88
743
1.19
0.85
2.4
1.9
2.90
4.57
mg/l
1.38
66
541
77
643
1.21
0.84
1.5
1.7
12.30
12.11
u/ml
0.01
20
173
55
443
1.25
0.84
2.2
2.0
3.07
4.19
iu/l
0.79
19
191
431
4032
1.09
0.83
1.9
1.7
—
—
—
0
0
1507
14776
1.09
0.83
25.5
16.6
13.55
13.40
%
4.78
1494
14607
18
121
1.49
0.82
10.7
9.5
57.00
54.08
u/ml
—
5
39
78
654
1.20
0.82
1.8
1.5
0.00
0.25
iu/ml
—
9
107
107
925
1.17
0.80
1.4
1.3
—
—
—
0
0
408
3816
1.09
0.79
3.9
3.2
1.02
1.43
kg/l
0.50
258
2474
17
114
1.50
0.79
1.1
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
240.45
—
0
15
71
593
1.20
0.78
1.1
1.2
4.30
3.19
u/ml
0.22
41
344
12
187
0.64
0.78
12.4
22.4
1328.67
1378.39
nmol/l
0.08
12
181
73
612
1.20
0.78
1.3
1.3
—
—
—
0
0
26
191
1.37
0.77
1.6
2.0
—
—
—
0
0
12
75
1.60
0.75
1.2
1.4
—
—
—
0
0
12
75
1.60
0.75
1.2
1.4
—
—
—
0
0
22
159
1.39
0.72
1.0
1.1
—
—
—
0
0
9
56
1.61
0.72
1.1
1.1
—
—
—
0
0
9
57
1.58
0.71
1.2
1.2
—
—
—
0
0
5
26
1.93
0.70
1.6
1.8
—
—
—
0
0
5
26
1.93
0.70
1.2
1.8
—
—
—
0
0
59
492
1.21
0.68
1.1
1.1
4.94
8.00
eliau/ml
0.41
11
88
10
61
1.64
0.68
7.5
3.9
17.03
86.27
u/ml
—
10
61
7
121
0.58
0.67
1.1
1.6
—
—
—
0
0
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
38
304
1.25
0.65
1.1
1.1
1.83
3.22
eliau/ml
0.73
17
145
5
29
1.73
0.64
1.2
1.0
—
—
—
0
0
37
296
1.25
0.64
1.1
1.1
0.40
2.46
—
7
55
13
87
1.50
0.63
1.6
1.5
0.68
0.49
e9/l
1.40
13
87
46
379
1.22
0.62
1.1
1.1
73.59
112.10
iu/ml
—
7
93
17
122
1.40
0.60
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
27
210
1.29
0.58
1.9
1.4
286.80
286.78
mosm/kgh2o
0.00
20
161
15
106
1.42
0.57
1.3
1.1
—
—
—
0
0
1519
15405
0.94
0.56
24.7
16.5
334.63
334.84
g/l
0.40
1513
15325
6
36
1.67
0.56
1.2
1.0
—
—
—
0
0
49
411
1.20
0.56
1.4
1.7
—
—
—
0
0
89
1007
0.88
0.56
1.1
1.1
0.71
0.69
ratio
0.09
11
97
23
176
1.31
0.56
1.3
1.5
—
—
—
0
0
81
711
1.15
0.55
1.3
1.3
201.31
226.73
miu/ml
0.24
32
325
60
515
1.17
0.54
1.1
1.1
1.03
1.20
u/ml
0.15
29
263
134
1216
1.11
0.53
1.7
1.5
—
—
—
0
0
23
178
1.30
0.53
1.3
1.5
—
—
—
0
0
23
178
1.30
0.53
1.3
1.5
—
—
—
0
0
59
508
1.17
0.52
1.1
1.1
3.50
2.21
u/ml
0.30
33
288
12
83
1.45
0.51
1.3
1.4
12.25
12.82
u/l
0.12
12
83
42
351
1.20
0.51
1.2
1.1
—
—
—
0
0
6
40
1.50
0.51
1.0
1.3
—
—
—
0
0
18
135
1.34
0.51
1.7
2.4
29.88
18.28
mg/l
—
8
58
11
75
1.47
0.50
1.3
1.7
0.91
3.07
u/field
0.54
11
62
1596
15769
1.06
0.50
4.6
4.1
1.39
1.38
mmol/l
0.25
1523
15036
47
402
1.17
0.46
2.1
1.5
—
—
—
0
0
124
1132
1.10
0.46
1.7
1.9
0.38
0.32
mg/l
0.60
63
616
741
7196
1.05
0.45
2.0
1.9
1.41
1.48
mmol/l
1.30
638
6316
309
2931
1.06
0.45
2.5
2.3
—
—
—
0
0
45
387
1.17
0.42
1.1
1.1
7.50
7.46
u/ml
0.00
20
192
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
5
37
1.35
0.37
3.2
3.4
6.00
4.35
ug/l
—
5
37
17
134
1.27
0.37
1.6
1.5
85.94
77.75
umol/l
0.42
17
134
10
72
1.39
0.37
1.1
1.3
—
—
—
0
0
23
189
1.22
0.36
1.3
1.2
290.00
160.57
titre
—
5
35
23
189
1.22
0.36
1.2
1.2
13.61
16.62
u/ml
0.30
12
83
38
330
1.15
0.34
1.6
1.3
—
—
—
0
0
12
91
1.32
0.33
1.1
1.1
—
13.20
—
0
5
17
136
1.25
0.33
1.2
1.5
1.83
3.45
u/ml
—
9
79
594
6101
0.96
0.33
3.5
3.4
21.19
21.35
%
0.08
240
2406
32
371
0.86
0.33
1.7
1.5
58.34
57.33
ug/l
0.05
32
371
6
46
1.31
0.33
4.3
2.4
9.63
10.45
kpa
—
6
46
6
46
1.31
0.33
4.3
2.4
6.15
4.87
kpa
—
6
46
1883
18756
1.10
0.33
30.5
20.2
90.43
90.21
fl
1.23
1875
18618
25
210
1.19
0.32
2.2
1.4
1.89
1.41
promille
0.53
17
167
1882
18748
1.09
0.31
30.6
20.3
250.37
250.17
e9/l
0.05
1862
18438
1883
18759
1.09
0.31
30.6
20.3
4.62
4.67
e12/l
3.68
1857
18415
1883
18759
1.09
0.31
31.9
20.9
41.25
42.39
%
2.21
1875
18609
20
165
1.21
0.31
1.3
1.5
—
—
—
0
0
461
4751
0.96
0.30
2.8
2.7
0.69
0.68
ug/l
0.11
237
2544
15
120
1.25
0.30
1.3
1.7
—
—
—
0
0
20
166
1.21
0.30
1.3
1.5
—
—
—
0
0
20
166
1.21
0.30
1.3
1.5
—
—
—
0
0
75
688
1.09
0.29
1.6
1.8
—
—
—
0
0
333
3212
1.04
0.29
2.2
1.9
1.45
1.46
%
0.11
300
2888
1883
18763
1.09
0.29
30.6
20.3
7.07
6.69
e9/l
0.71
1857
18410
1883
18764
1.09
0.28
30.9
20.4
139.07
140.66
g/l
4.26
1875
18626
1266
12516
1.03
0.27
3.5
3.2
—
—
—
0
0
8
65
1.23
0.27
1.1
1.8
—
—
—
0
0
8
65
1.23
0.27
1.7
2.5
21.77
16.68
umol/l
—
8
65
11
86
1.28
0.26
1.6
2.2
161.91
198.72
u/l
2.57
11
86
282
2720
1.04
0.25
2.5
2.2
—
—
—
0
0
9
74
1.22
0.25
1.2
1.2
—
—
—
0
0
17
202
0.84
0.24
1.4
1.2
—
—
—
0
0
20
234
0.85
0.24
1.9
1.6
—
—
—
0
0
124
1172
1.06
0.24
2.4
2.3
12.67
10.18
ug/l
0.29
115
1069
60
652
0.92
0.24
1.6
1.4
—
—
—
0
0
772
7589
1.03
0.24
4.2
4.1
1.73
1.81
ug/l
0.23
719
7075
42
464
0.90
0.23
1.6
1.7
—
—
—
0
0
1682
16725
1.04
0.23
5.7
5.2
2.75
2.79
mmol/l
1.18
1616
16043
31
276
1.13
0.22
1.5
1.2
—
—
—
0
0
167
1599
1.05
0.22
2.5
2.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
11
89
1.24
0.21
1.0
1.1
102.38
210.18
iu/ml
2.08
11
89
306
2973
1.03
0.20
4.5
3.7
948.64
675.58
ng/l
0.32
227
2126
14
117
1.20
0.20
2.4
2.3
675.78
616.83
ml
—
9
80
46
423
1.09
0.19
1.1
1.1
9.88
4.79
u/ml
0.57
22
227
12
100
1.20
0.18
1.2
1.4
—
—
—
0
0
7
60
1.17
0.17
1.3
1.5
—
—
—
0
0
7
60
1.17
0.17
1.3
1.5
—
—
—
0
0
35
379
0.92
0.15
1.4
1.4
—
—
—
0
0
24
217
1.11
0.14
1.3
1.4
0.51
0.59
nmol/l
0.62
24
207
33
357
0.92
0.14
2.8
2.3
153.23
150.81
ug/min
0.01
19
230
44
415
1.06
0.11
1.8
1.8
—
—
—
0
0
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
24
223
1.08
0.09
1.3
1.4
—
0.26
nmol/l
—
0
18
31
328
0.94
0.08
1.3
1.2
36.53
24.68
u/l
0.32
31
284
20
186
1.08
0.07
1.3
1.4
0.18
0.20
nmol/l
0.29
13
147
58
561
1.03
0.06
1.6
1.5
74.69
59.49
ug/l
0.28
50
484
53
512
1.04
0.06
1.5
1.5
1.09
1.13
ratio
0.11
34
326
53
512
1.04
0.06
1.5
1.5
0.85
0.95
ratio
1.82
34
326
53
512
1.04
0.06
1.5
1.5
0.99
1.16
ratio
0.63
35
326
1666
16627
1.01
0.06
5.4
4.8
4.59
4.64
mmol/l
1.41
1605
15996
48
463
1.04
0.06
2.4
2.5
25.71
44.05
u/ml
0.99
48
442
52
503
1.03
0.06
1.5
1.5
—
—
—
0
0
26
271
0.96
0.04
1.0
1.1
—
—
—
0
0
12
111
1.08
0.04
2.1
2.1
0.26
3.57
u/ml
—
5
37
15
141
1.06
0.03
5.1
5.3
318.32
67.51
u/ml
—
8
44
15
141
1.06
0.03
15.2
13.8
0.67
0.63
mmol/l
0.32
15
131
17
161
1.06
0.03
1.1
1.1
4.47
5.93
iu/ml
—
6
46
11
102
1.08
0.03
1.8
1.6
—
—
—
0
0
37
362
1.02
0.01
1.8
1.5
—
—
—
0
0
12
115
1.04
0.00
1.1
1.2
9.00
7.97
mm/h
0.11
12
115
23
225
1.02
0.00
1.2
1.4
70.39
149.86
pmol/l
0.78
23
217
137
1365
1.00
0.00
2.3
2.2
—
—
—
0
0
99
991
1.00
0.00
1.8
1.6
1049.62
962.06
mu/l
0.23
86
855
1657
16571
1.00
0.00
5.4
4.7
1.35
1.36
mmol/l
0.99
1589
15882
37
374
0.99
0.00
1.1
1.1
0.19
0.84
u/ml
0.61
11
141
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
9.40
—
0
5
0
6
0.00
0.00
0.0
6.0
—
0.24
—
0
6
7
72
0.97
0.00
10.6
8.2
1.64
412.32
ug/l
—
7
52
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.1
21.08
42.32
iu/ml
—
6
63
9
99
0.91
-0.00
2.7
2.2
235.78
143.32
nmol/l
—
9
90
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
83
0.96
-0.00
1.8
1.2
197.13
201.30
mmol/24h
—
8
83
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VARICELLA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VARICELLA | 2.371 [1.77, 3.17] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.578 |
During the follow-up period (1.1.1998 — 31.12.2019), 230 out of 5335 females with AB1_VARICELLA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VARICELLA | 2.514 [1.95, 3.24] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 291 out of 6337 males with AB1_VARICELLA died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VARICELLA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.272% | 0.409% |
| 5 | 1.555% | 2.968% |
| 10 | 3.899% | 7.396% |
| 15 | 7.226% | 14.074% |
| 20 | 12.554% | 22.812% |
Relationships between endpoints
↥Index endpoint: AB1_VARICELLA – Varicella [chickenpox]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data